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Abstract
Cell states in haematopoiesis are controlled by complex circuits, involving master
regulators transcription factors and a growing family of RNA species, shaping
cell phenotype, its maintenance and plasticity. Amongst RNA species, circular
RNAs (circRNAs) are rapidly gaining the status of particularly stable transcriptome
members with distinctive qualities. Regarding molecular functions, circRNAs
modulate host gene expression, compete for binding of microRNAs, RNA-binding
proteins and translation initiation, and participate in regulatory circuits. RNA-seq
studies identified thousands of circRNAs with developmental stage- and tissue-
specific expression corroborating earlier suggestions that circular isoforms are a
natural feature of the cell expression program. CircRNAs are abundantly expressed
and highly regulated also in the haematopoietic compartment, as described by
recent and preliminary studies on circRNAs in blood cells.
In my PhD project we focused on the development of a bioinformatics pipeline
to detect, quantify and characterize circRNAs from RNA-seq data, by combining
both publicly available tools and custom scripts. Aiming to increase the discovery
power of the pipeline as well as results robustness, we combined four programs for
circRNA detection in parallel.
The pipeline was tested on a publicly available dataset of haematopoietic lineage
cells such as Haematopoietic Stem Cells, Lymphoid progenitors, Myeloid Progen-
itors and Megakaryocyte–Erythroblast Progenitors. This pilot analysis allowed
to retrieve a great number of circRNAs despite features of the data that were not
optimal for circRNA detection. Major results from the pilot study were the identi-
fication of distinct sets of circRNAs specifically expressed in different cell types,
and the feasibility and convenience of circRNA detection in published datasets to
complement the original studies.
In parallel, we studied circRNA and linear RNA expression in differentiated cells
of the haematopoietic compartment, specifically B cells, T cells and Monocytes. We
produced RNA-seq data of 12 samples, obtained by cell sorting from peripheral blood
of healthy donors and using ribosomal RNA depletion for the library construction.
Out of the over 115 000 detected backsplices supported by at least two reads, we
selected putative circRNAs found by at least two methods, gaining also indirect
support that most of them are truly circular forms thanks to independent evidence.
This subset consists of 26 211 circRNAs expressed by 7307 different genes, with
38.6 % of genes expressing one circRNA each, and 40.7 % of genes producing from
2 to 5 different circular isoforms and the remaining genes expressing a higher
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number of circRNAs. The large majority of circRNAs are exonic, 11.5 % have
backsplice ends falling into intronic regions and only a few (2.5 %) probably derive
from genomic regions annotated as intergenic. Comparison with the analysis
of the linear transcriptome pointed out that the expression levels of linear and
circular RNAs expressed from the same gene have only a very slight tendency
toward positive correlation, with most of the pairs showing scarce or even negative
correlations, suggesting specific regulatory mechanisms underlying the expression
of circRNAs.
The comparison between B cells, T cells and Monocytes indicated groups of
circRNAs expressed in all the cell types and specific of each cell type. Unsupervised
analyses of expression profiles showed for the first time specificities of circRNA
expression associated to different blood cells. B cells and T cells circRNA-omes
are similar from quantitative and qualitative points of view, whereas Monocytes
express a lower number of circRNAs and have a more specific circRNA-ome. Indeed,
differential expression tests outlined sets of circRNAs with significantly variable
expression in B cells compared to Monocytes (2589), B cells compared to T cells
(168) and Monocytes compared to T cells (977). Differentially expressed circRNAs
are associated to genes enriched in protein products involved in key blood pro-
cesses and pathways. Finally, we focused on 74 circRNAs upregulated in B cells
compared to both Monocytes and T cells, 40 upregulated in T cells and 159 upreg-
ulated in Monocytes, for a total of 273 circRNAs with differential expression and
cell specificity. Additional criteria for circRNA prioritization selected circRNAs
associated to genes with key functions in haematopoiesis, or altered/deregulated
in haematologic malignancies. Prioritized circRNAs will undergo experimental
validations. The sequence analyses for in silico prediction of possible circRNAs
functions, as presence of multiple miRNA binding sites, protein binding motifs, or
open reading frames, will be the starting point for experimental studies to better
elucidate the functions of more promising circRNAs.
In conclusion we performed the first study of circRNAs in normal B cells, T cells
and Monocytes grounding on several biological replicates of each cell type being
informative on circRNA differential expression. The integration of circular and
linear RNA expression profiles with gene annotations and functions, in conjunction
with differential expression data, produced new and original results. We showed
that taking into account circRNA expression might add definition to the represen-
tation of transcriptome variations in normal haematopoiesis, posing the basis to
better comprehend the role of circRNAs in the regulatory circuits of blood cells
differentiation, which is a prerequisite for transferring this knowledge to research
on haematological malignancies.
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Sommario
Il differenziamento cellulare durante l’ematopoiesi è controllato da circuiti com-
plessi, che coinvolgono fattori di trascrizione e diverse specie di RNA che concor-
rono a stabilire il fenotipo delle cellule e a mantenerlo, e ne assicurano anche la
plasticità. Negli ultimi anni sono emerse chiaramente la diversificazione e l’impor-
tanza di varie classi di RNA non codificanti. Tra questi, gli RNA circolari (circRNA),
prodotti mediante backsplicing di trascritti primari, si stanno rapidamente affer-
mando come membri del trascrittoma particolarmente stabili e con ruoli biologici
rilevanti, prevalentemente regolativi. Per quanto riguarda le loro funzioni moleco-
lari i circRNA sono in grado di modulare l’espressione del gene da cui derivano,
possono competere per il legame di microRNA, regolando quindi l’espressione dei
loro target, ma anche interagire con proteine che legano l’RNA modulandone le
funzioni. Diversi circRNA la cui funzione è stata chiarita recentemente partecipano
ad importanti assi o circuiti regolatori, intervenendo in processi chiave, di grande
rilevanza anche in ambito oncologico, quali la regolazione del ciclo cellulare, il
controllo dell’espressione di oncogeni e l’attivazione di specifiche vie di segnale.
Studi di RNA-seq hanno identificato migliaia di circRNA con espressione specifica
per lo stato di sviluppo o per il tipo di tessuto, corroborando precedenti indicazioni
che le isoforme circolari siano una sfaccettatura del programma cellulare, tanto
interessante quanto precedentemente sottovalutata. I circRNA sono molto espressi
e fortemente regolati anche nel comparto ematopoietico, come mostrato da alcuni
studi preliminari sulla loro presenza nelle cellule del sangue. L’identificazione dei
circRNA mediante RNA-seq si basa sulla ricerca di backplice, ovvero di sequenze
che non mappano linearmente sul genoma ma che sono formate dalla fusione di due
sequenze in maniera non colineare, e ciò richiede specifici metodi computazionali.
In questo progetto di dottorato è stata sviluppata una pipeline bioinformatica
che consente di identificare, quantificare e caratterizzare i circRNA a partire da dati
di RNA-seq, mediante quattro metodi computazionali già disponibili utilizzati in
parallelo, e di combinare ed elaborare i risultati grazie a una serie di programmi
scritti appositamente.
La pipeline è stata testata su un dataset di cellule del lineage ematopoietico dispo-
nibile nei database pubblici, che contiene dati di sequenziamento di cellule staminali
ematopoietiche, di progenitori linfoidi, di progenitori mieloidi e di progenitori di
megacariociti ed eritroblasti. Questa analisi pilota ci ha consentito di identificare
molti circRNA nonostante le caratteristiche dei dati non fossero ottimali per questo
tipo di analisi. I principali risultati di questo studio pilota sono stati l’identificazione
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di sottogruppi distinti di circRNA specificamente espressi in diversi tipi cellulari,
e l’indicazione di fattibilità e convenienza dell’applicazione di questo approccio
anche su dati già pubblicati per ampliare e complementare gli studi originali che
non avessero preso in considerazione i circRNA.
Il progetto principale si è quindi focalizzato sull’analisi dell’espressione di cir-
cRNA e RNA lineari in cellule differenziate del comparto ematopoietico. Sono
stati prodotti dati RNA-seq di linfociti B, linfociti T e monociti ottenuti tramite
sorting da sangue periferico di donatori sani, per un totale di 12 campioni ad alta
profondità di sequenziamento e processati mediante un protocollo di sottrazione
dell’RNA ribosomale particolarmente adatto per lo studio dei circRNA. Degli oltre
115.000 backsplice identificati da almeno 2 reads di sequenziamento considerando
l’insieme dei 12 campioni analizzati, sono stati selezionati 26.211 circRNA iden-
tificati da almeno due metodi computazionali. Considerato che studi precedenti
basati sull’arricchimento di circRNA in seguito al trattamento con RNAsi R hanno
chiarito che i backsplice identificati da almeno due metodi indipendenti sono più
affidabili, questo insieme di 26.211 circRNA selezionati dovrebbe risultare robusto.
Essi risultano espressi da 7.307 geni diversi, di cui il 38,6% esprime un solo circRNA
per gene, il 40,7% produce da 2 a 5 isoforme circolari e i restanti geni ne esprimono 6
o più. La maggioranza dei circRNA identificati è esonica, l’11,5% ha gli estremi della
giunzione che mappano su regioni annotate come introniche nel genoma, e solo il
2,5% probabilmente deriva da regioni genomiche annotate come intergeniche.
I livelli di espressione dei circRNA e degli RNA lineari espressi dallo stesso
gene hanno una leggere tendenza a correlare positivamente, mentre la gran parte
delle coppie mostrano scarsa o negativa correlazione, suggerendo che ci siano
dei meccanismi di regolazione specifici che sottendono all’espressione di circRNA.
Questo dato è in linea con studi recentissimi che presentano lo splicing alternativo
delle isoforme circolari come un ulteriore meccanismo che genera complessità nello
splicing dei trascritti eucariotici.
L’analisi non supervisionata dei profili d’espressione dei circRNAs in linfociti B,
linfociti T e monociti ha mostrato per la prima volta la specificità dell’espressione
di circRNA associata ai tipi cellulari considerati. I circRNAomi di linfociti B e T
risultano simili sia dal punto di vista qualitativo che quantitativo, mentre invece i
monociti esprimono un numero minore di circRNA e hanno un circRNAoma più
specifico. Il confronto tra tipi cellulari ha indicato gruppi di circRNA espressi in tutti
e tre i tipi cellulari, e altri specificamente espressi in un solo tipo. L’analisi statistica
dell’espressione differenziale ha evidenziato dei gruppi di circRNA con espressione
significativamente diversa nei linfociti B confrontati con monociti (2589), linfociti B
confrontati con linfociti T (168) e monociti confrontati con linfociti T (977). CircRNA
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differenzialmente espressi sono associati a geni le cui proteine sono coinvolte in
processi e pathway chiave nel comparto ematopoietico. Infine sono stati evidenziati
circRNA differenzialmente espressi e specificamente up-regolati in un solo tipo
cellulare: 74 circRNA risultano up-regolati nei linfociti B in confronto a monociti
e linfociti T, 40 nei linfociti T e 159 nei monociti, per un totale di 273 circRNA
con espressione differenziale e specificità cellulare. I circRNA differenzialmente
espressi, altri con altissima espressione o derivati da geni particolarmente importanti
nell’ematopoiesi normale o maligna, sono stati selezionati per ulteriori analisi in
silico e alcuni verranno validati sperimentalmente. L’analisi della sequenza dei
circRNA per la predizione in silico di siti di legame multipli per miRNA, motivi di
legame per proteine oppure open reading frames, fornirà utili predizioni funzionali
e sarà anche punto di partenza per studi sperimentali focalizzati su alcuni circRNA
particolarmente promettenti.
In conclusione, questa tesi costituisce il primo studio sui circRNA in linfociti
B, linfociti T e monociti sani, fondato su replicati biologici di ogni tipo cellulare.
L’integrazione dei profili d’espressione di circRNA e RNA lineari con l’annotazione
dei geni e le funzione, congiuntamente all’espressione differenziale, ha prodotto
risultati nuovi e originali. Lo studio è molto informativo sull’abbondanza e la diver-
sificazione dei circRNA espressi e fornisce numerosi nuovi dati sui circRNA, nonché
robuste indicazioni sull’espressione differenziale dei circRNA nelle cellule consi-
derate. Abbiamo dimostrato che considerare l’espressione dei circRNA aggiunge
definizione alla rappresentazione delle variazioni del trascrittoma nell’ematopoiesi
normale, ponendo le basi per ampliare la comprensione del ruolo dei circRNA nei
circuiti regolatori del differenziamento delle cellule del sangue, prerequisito per
trasferire queste conoscenze alla ricerca nell’ambito delle patologie ematopoietiche.
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1 Introduction
1.1 Transcriptome variation and regulatory
circuits in haematopoiesis
Human blood production releases each day 1011 blood elements into the blood
flow, mostly red blood cells and platelets, and leukocytes. These blood cell types
derive from a small population of haematopoietic stem cells (HSCs), that expands
and differentiates into progenitor cells with increasingly restricted lineage choice.
Studying haematological malignancies and model organisms [1] helped to iden-
tify many critical genes and mechanisms regulating haematopoietic development.
Underlaying haematopoiesis a large number of interleaved molecular circuits are
regulated by sets of transcription factors [2].
Together with protein regulators and effectors, the mechanisms are also regulated
by non-coding RNAs (ncRNAs). The action of miRNAs for example has been
characterised in diverse phases of the haematopoiesis.
For example Chen et al. in their 2014 study [3] described that in less differenti-
ated stages the majority of sequenced transcripts derived from non-coding genes,
while in more differentiated stages it was the opposite. The non-coding family
is wide and varied, and alongside with miRNAs contains long non-coding RNAs
(lncRNAs) and circular RNAs (circRNAs), a novel class of ncRNAs with a strong
regulatory potential. CircRNAs are covalently closed RNA molecules produced by
a process of “backsplicing”, a particular type of alternative splicing [4], and have
been demonstrated to be present in many different cell types and also in blood
cells [5].
Alternative splicing has an important role in disease, with 15 % of disease-causing
constitutional mutations located within splice sites and more than 20 % of missense
mutations lying within predicted splicing elements [6]. Studies have also revealed
that somatic mutations of splicing factor genes occur frequently in haematological
cancers, including myelodysplasia and chronic lymphocytic leukaemia [7–9].
1.2 CircRNAs
CircRNAs are covalently closed RNA molecules, in which the 3 ′- and 5 ′-ends
are linked in a non-collinear way by a process called backsplicing [4]. Unlike in
linear RNA splicing, a splice donor site is joined to a splice acceptor site upstream
1
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Figure 1.1: CircRNAs are produced by backsplicing and combinations of exons and introns
give rise to different products, including single circularised exons, circRNAs formed by
two or more exons, by exon and retained intron sequences (EI-circRNAs) and by intronic
sequences only.
in the primary transcript, yielding a circRNA [4]. CircRNAs can be formed by
circularisation of a single exon, two or more exons [10], both exon and intron
sequences (exon–intron circRNA, EI-circRNA) [11] or intronic sequences only
(circularised intron RNA, ciRNA) [12] (Figure 1.1). Several circular isoforms can be
produced from a given gene and different circRNAs from the same gene may show
distinct expression profiles, as reported for circSTAU2a and circSTAU2b [13].
Circularity confers specific properties to circRNAs: they are highly stable, resis-
tant to RNAse R, have longer half-lives compared with linear RNAs [14, 15] and
tend to accumulate in cells with a low proliferation rate [16]. Detection of circRNA
in human body fluids such as plasma [17] and saliva [18] indicates circRNAs as
potential disease biomarkers.
The first description of circRNA dates back to several decades ago. Recently,
circRNAs were relaunched by RNA-seq-based studies as an RNA species with high
relevance for molecular biology and molecular oncology and today over 10 000
human circRNAs have been identified [19–25].
CircRNAs are non-poly-adenylated and coincidental discovery of circRNA in the
past can be attributed to RNA extraction methods that mainly used polyA selection.
Naturally occurring single-stranded covalently closed RNA molecules were first
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described in plant viroids [26] and were valued for their peculiar structure that
allows for rolling circle replication [4]. A few studies in the nineties reported
non-canonical splicing with scrambled exons of candidate tumour suppressor gene
DCC [27], ‘missplicing’ of ETS1 transcripts [28] and murine Fmn [29], and exon
circularisation in nuclear extracts [30]. Moreover, whereas early in development the
mRNA of therian SRY is translated into the protein that triggers the sex-determining
transcriptional cascade, in adults SRY transcripts are found as cytoplasmic circular
SRY (cSRY ) not particularly bound to polysomes [31] and later proven to efficiently
sponge miR-138 [32]. Other primary RNAs were found to be processed into circRNA
isoforms such as MLL (KMT2A) [33], ETS1 [34], CYP2C18 [35], SLC8A1 [36] and
dystrophin (DMD) [37] transcripts. Examples of circRNAs corresponding to linear
non-coding RNA, as well as antisense RNA were also detected [38, 39].
Most of the above-mentioned studies postulated relevant biological functions
for circular RNAs but were only confined to certain genes. In any case, shortly
after publication of circular forms of an INK4/ARF-associated non-coding RNA [38]
numerous studies embarked on transcriptome-wide circRNA analysis showing
developmental stage- and tissue-specific expression, and specific regulatory roles
for circRNAs were suggested [10, 21]. These new data triggered the interests of the
scientific community resulting in the development of molecular methods to study
circRNAs and of microarray platforms to measure expression levels of circRNAs
(Figure 1.2), as well as the implementation of bioinformatics software to detect
and discover circRNAs from RNA-seq data (Table 1.1, p. 21) posing the basis for
further experimental circRNA characterization, and for circRNA quantification
and differential expression testing. Moreover, several available circRNA databases
and web resources (Box 1.1) could be rather useful to explore putative circRNA
interactions and functions.
Several studies on circRNAs in blood cell types and haematologic malignancies
were recently conducted and will be discussed below.
1.2.1 CircRNAs biogenesis
Backsplicing As anticipated, circRNA loops are generated by backsplicing from
immature RNA, where ends are joined in a non-collinear way. CircRNAs are
derived from Pol II transcripts just like linear transcripts. Backsplicing requires
the spliceosomal machinery [45–47] as revealed by treatment of HeLa cells with a
splice inhibitor followed by nascent RNA purification.
In the majority of cases, the generation of circRNA happens at the expense of
their corresponding mRNA isoforms and is characterised by the usage of canonical
splice sites that precisely flank head-to-tail junctions of circular transcripts. In
3
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Figure 1.2:Molecular methods for circRNA detection, validation and study. (A) CircRNA
detection from RNA-seq data grounds on the identification of sequence reads encom-
passing the backsplice junction. (B) Backsplice reads map to the genome in chiastic
order (two segments of a single read align separately in reverse order) due to the back-
splicing in circRNAs biogenesis. (C) Convergent primers (white arrows) designed in
adjacent spliced exons amplify both linear and circular isoforms, whereas primers that
are divergent in the linear transcripts (black arrows) can be used to specifically amplify
the circular isoform. (D) PolyA enrichment protocols deplete circRNAs, whereas ribo-
some depletion and RNAse R protocols enrich circRNAs. (E) RNAse R digestion before
reverse-transcription PCR lowers the amount of false-positive amplicons facilitating
circRNA validation. (F) Gel trap electrophoresis allows isolate the circular and linear
fractions of the input RNA, as circRNAs are hold in the well. (G) Two-dimensional
acrylamide gel electrophoresis separates the circular RNA fraction in an off-diagonal
curve. (H) RNA migration in agarose gel before and after a mild RNAse H treatment
resulting in a single cut per molecule shows that circular molecules bearing a backsplice
junction are discriminated from linear ones deriving from a duplication event, as only
circRNA results in a single band after being cut once. (F)–(H) re-elaborated from Jeck &
Sharpless, 2014 [44].
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circBase Simple circRNA database that provides a searchable table of circRNAs
identified by several studies (five on human data) that can be useful to sort
newly identified from known circRNAs [40].
http://www.circbase.org/
starBase v2.0 Focuses on RNA–RNA and protein–RNA interaction networks
inferred from CLIP-Seq data sets. Among others, in the miRNA–lncRNA
section, it includes predicted miRNA–circRNA interactions and can be
searched to identify known circRNA that potentially sponge a specific
miRNA [41]. http://starbase.sysu.edu.cn/
Circ2Traits Useful to explore potential associations of circRNAs with dis-
eases based on predicted interactions of circRNAs with disease-associated
miRNAs and on the overlap between disease-associated SNPs to circRNA
loci [42]. http://gyanxet-beta.com/circdb/
CircNet Provides expression profiles of circRNAs in 464 RNA-seq samples,
with circRNA sequences and annotations in term of overlapping genes
and interactions [43]. http://circnet.mbc.nctu.edu.tw/
Box 1.1:Main web resources dedicated to circRNAs.
some cases, transcripts of specific genes are predominantly spliced into the circular
isoform [19, 20]. Ashwal-Fluss et al. [45] demonstrated that circularisation and
splicing of linear forms compete against each other. Kelly et al. [48] confirmed
a direct correlation between exon skipping and circularisation. Thus, circRNA
biogenesis and regulation of mRNA production are tightly linked.
CircRNAs regulatory features CircRNA-forming exons are often flanked by
particularly long introns, possibly reducing splicing efficiency [20, 24]. Moreover, in
humans these long introns are markedly enriched in ALU repeats [20] and comple-
mentary sequences in introns are involved in specific folding of primary transcripts
that favour circularisation [45]. In the Sry gene, the activation of an upstream
promoter triggers the synthesis of a primary transcript containing inverted repeats
needed for circRNA production [49]. As drosophila RNA circularisation does not
appear to be driven by structural complementarity of exon-bordering sequences
but only determined by the length of exon-flanking introns, inverted repeats alone
do not fully explain the production of circRNAs in eukaryotes. In addition, regu-
lation of the dynamic expression of circRNAs in different cell types is likely also
dependent on control by trans-acting factors [50].
5
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Trans-acting factors Besides the role of flanking sequence elements, introns
encasing circRNAs are highly enriched in RNA A-to-I editing events [20]. In
fact, knock-down of RNA-editing enzyme ADAR1 upregulated circRNA expres-
sion, favouring a mechanism of circRNA biogenesis whereby ADAR1 antagonises
circRNA expression by melting stems of RNA-RNA interactions within introns that
putatively promote circularisation [20].
The Muscleblind (MBL) family of splicing factors was also shown to take part
in the regulation of circRNA production by binding specific intronic sites flanking
circularised exons [45]. Intriguingly, in the fly circRNA isoform expression of MBL
itself is regulated by MBL protein. Decrease of circRNA expression after MBL
knock-down supports a circRNA-promoting role for MBL proteins [45].
In addition, RNA-binding protein (RBP) Quaking (QKI) regulates the formation
of circular RNAs [51]. QKI dimers bind to specific bipartite sequences termed QKI
response elements that are present in many RNAs, including coding mRNAs and pri-
mary miRNAs. Conn et al. [51] investigated the role of QKI in promoting circRNA
biogenesis in transforming growth factor-β-induced epithelial-mesenchymal tran-
sition of the epithelial HMLE cell line, demonstrating that the knock-down of the
QKI-5 isoform specifically decreases the formation of circRNAs and that insertion of
synthetic QKI response elements in introns mediates circRNA formation. Metabolic
tagging of nascent RNAs with 4-thiouridine has been used to study the link between
nascent circRNA processing and transcription [25] showing that the efficacy of
circRNA processing from primary transcripts is extremely low. This study also
clarified that circRNAs are largely processed post-transcriptionally and confirmed
that circRNAs are stable, being thus abundant at a steady-state level and tending to
accumulate particularly in cells with low proliferation rates [16].
Backsplice as a new form of alternative splicing Alternative RNA splicing
is a complex tightly regulated phenomenon. Since the discovery of split genes
robust knowledge was built on splicing prevalence, on complexity of splicing
patterns and on molecular mechanisms that determine, regulate or change splicing,
including RNA-protein interactions (splicing factors with in cis regulatory sites
termed silencers or enhancers), RNA-RNA base-pairing interactions involving both
in trans acting RNAs and in cis secondary structure formation, and also chromatin-
based effects [52].
Disease-causing mutations occur in splice sites or in regulatory elements, as
well as in genes that encode splicing factors (U2AF1, SRSF2, SF3B1 and ZRSR2) and
there is much interest in developing antisense oligonucleotides to control splicing
patterns and using genome editing to correct disease-causing splicing defects.
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Alternative splicing is highly and commonly deregulated in cancer cells [53–55]
and specifically impacts prognosis and disease course of myeloid malignancies,
including chronic lymphocytic leukaemia, acute lymphoblastic leukaemia (ALL),
acute myeloid leukaemia and myeloproliferative neoplasms [56–59].
As circRNA biogenesis and splicing are interleaved processes, it can be hypothe-
sised that mutations of splicing factors and/or alterations of regulatory elements
have an impact on circRNA biogenesis. RBPs involved in circRNA biogenesis might
drive developmental regulation of circRNA formation and show deregulation in
disease. Distinct expression levels of ADAR1, MBNL1 and QKI in normal bone
marrow compared with B-cell leukaemia subtypes (Figure 1.3) encourage investiga-
tions as also subtle expression variations of ADAR1 were shown to be relevant for
RNA circularisation [13].
Alternative splicing is a key mechanism through which fundamental processes
during haematopoiesis are regulated [3], posing the basis to interpret the conse-
quences of genetic variation. Similarly, there is high demand to study circRNA in
normal haematopoiesis, to connect biogenic mechanisms with biological functions
of circRNAs, to accumulate fundamental knowledge needed to understand disease
mechanisms and to inform strategies for therapeutic intervention.
CircRNA degradation As circRNAs are endogenous cell products one might
ask which endogenous mechanisms cells have to dispose of circRNA. In general,
RNA is degraded by the exosome, a multiprotein complex that reminiscently of
the proteasome forms a chamber with helicase activity, which unfolds and then
degrades RNA. The degradation is prevalently exoribonucleolytic from the 3 ′-end,
but the exosome catalytic subunit RRP44 also has endonuclease activity [61].
According to available evidences circRNAs are not degraded by treatments (as
tobacco acid pyrophosphatase plus terminator 5 ′-phosphate dependent exonuclease
or highly processive 3 ′- to 5 ′-exoribonuclease RNAse R digestion) that normally
degrade linear RNA with free ends [39]. Regarding degradation, in general miRNAs
can regulate cleavage of circRNAs. The better characterised path toward degrada-
tion of a circRNA is that of CDR1-as (circular antisense transcript deriving from
cerebellar degeneration-related protein 1 locus) that even presenting multiple miR-7
binding sites is completely resistant to miR-7-mediated degradation and also resis-
tant to miR-769-mediated degradation, whereas the binding of miR-671 to CDR1-as
directs Ago2-slicer-dependent cleavage [39].
Undoubtedly, our understanding of the regulation of circRNA turnover and en-
dogenous degradation mechanisms is limited. We can hypothesise that not only the
deregulation of circRNA synthesis but also its degradation are biologically relevant.
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Figure 1.3: Expression variation of enzymes involved in circRNA expression. Gene expres-
sion intensities of ADAR1, MBNL1 and QKI in samples of normal bone marrow and six
B-cell leukaemia subtypes carrying specific genetic aberrations (according to Haferlach
et al. [60]); expression data obtained with HG-U133 Plus 2.0 (Affymetrix, Santa Clara,
CA, USA).
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For instance, a lack of cleavage might result in undesired circRNA accumulation.
1.2.2 Conservation and functions
CircRNAs are evolutionarily conserved CircRNAs were described in many
eukaryotes from yeast to humans [62] and resulted very conserved at the nucleotide
level: Memczak et al. [21] analysed sequence conservation within circRNAs and
showed that 223 human circRNAs with conserved circularisation in mice were
significantly more conserved in the third codon positions than exons not engaged
in circular forms. CircRNAs are also depleted of polymorphisms in miRNA-binding
sites [63]. Beyond apparent sequence conservation, both paralogous and ortholo-
gous gene pairs have been reported to express circular transcripts: human HIPK2
and HIPK3, as well as murine Hipk2/3 produce circRNAs [20]. Also conservation
of circRNAs in terms of exonic sequences, bordering intronic sequences, precise
backsplice junctions and expression patterns in mammals and to some extent in
Drosophila has been recently reported [13]. The above indications of evolutionary
preservation point to a central position of circRNAs in core biological processes.
CircRNAs are seldom translated It has previously been shown that eukaryotic
ribosomes can initiate translation on circRNAs containing internal ribosome entry
site elements (Figure 1.4) producing long-repeating polypeptides in the presence
of a continuous open reading frame [64, 65]. Efficient circRNA translation can
occur in HEK293 [47] and HeLa cells [66]. Intriguingly, a circRNA can be a sort of
‘Möbius strip’ with translation generating proteins either recurrently, or variably
depending on whether or not the sequence length is a multiple of three nucleotides.
A small viroid circRNA directly translated through three completely overlapping
open reading frames shifting to a new reading frame at the end of each round has
been reported as a natural supercompact ‘nanogenome’ [67].
Even if in principle circRNAs can be translated, the majority of recently discov-
ered and characterised circRNAs seem to have limited coding potential: seldom
associated neither with messenger ribonucleoprotein particles nor with translation-
ally active polyribosomes, suggesting that circRNAs, as a species, are unlikely to
be translated into peptides [68]. The fact that in the same study mass spectrometry
failed to identify peptides encoded by backsplice junctions of circRNAs could be
due to low sensitivity or to the position of open reading frames outside junctions
and does not rule out that part of circRNAs can be translated in some cell types
and/or conditions.
A circRNA produced by murine Fmn [29] contains an active translation start
site not leading to protein synthesis. In this way, the circular form competes
9
1 Introduction
Figure 1.4: CircRNA functions. Elucidated circRNA functions include the ability to sponge
miRNAs thus regulating the silencing of canonical targets (for example, CDR1-as/ciRS-7
harbours 63 binding sites for miR-7) and participating to ceRNA networks; similarly
circRNAs could decoy RBPs ultimately regulating the functions in which RBPs are
implicated (for example, circ-Foxo3 forms a ternary complex with p21 andCDK2 arresting
cell cycle progression); circRNAs can also regulate in cis the expression if the gene from
which they derive through interactions with the U1 RNA in the U1 RNP in the nucleus
(for example, circEIF3J); moreover, circRNAs harbouring an IRES could be translated to
produce peptides or compete with mRNA translation (for example, circFMN contains an
active translation start site not leading to the protein synthesis).
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Figure 1.5: CDR1-as mechanism of action as a ceRNA. CDR1-as acts as a sponge for miR-
7, resisting miR-7 mediated degradation whereas it is sensible to miR-671 mediated
degradation. Figure from Guil & Esteller, 2015 [71].
with the linear mRNA both impacting on the linear transcript abundance and
providing an ‘mRNA trap’ that can sequester proteins of the translation initiation
complex. Also, Jeck & Sharpless [44] uncovered that many single-exon circRNAs
contain a translation start site [69], further exemplifying this mechanism of protein
expression regulation by circRNAs.
CircRNAs are efficient miRNA sponges and participate to competing en-
dogenous RNA networks As demonstrated by several studies, circRNAs with
multiple miRNA-binding sites are efficient miRNA sponges that participate in the
regulation of specific cellular pathways (Figure 1.4) [32, 70].
CDR1-as harbours 63 conserved binding sites for miR-7 displaying high miRNA-
binding capacity andmiRNA antagonist activity in the brain (Figure 1.5) [21, 32]. Fol-
lowing this functional description CDR1-as was renamed as circular transcript ciRS-
7 (circular RNA sponge for miR-7), called also CDR1-as/ciRS-7 . Notably, circRNA
is completely resistant to miR-7-mediated target destabilization and strongly sup-
presses miR-7 activity, resulting in increased levels of miR-7 targets, including
EGFR and IRS2.
The previously mentioned cSRY decoys miR-138, for which it displays 16 target
sites [20, 32]. Circ-ITCH, a circRNA downregulated in carcinomas, was demon-
strated to be a sponge for miR-7, miR-17 and miR-214, by increasing the level
of ITCH and ultimately inhibiting the Wnt/β-catenin pathway [70, 72]. Another
11
1 Introduction
circRNA (hsa_circ_001569) that acts as a sponge for miR-145 upregulates its targets
enhancing cell proliferation and invasion of colorectal cancer [73].
Recently, specific circRNA–miRNA axes have been shown to regulate cancer-
related processes. CircRNAs can have both cancer-promoting and -suppressing
roles, depending on the molecular circuits in which they are involved and on the
role of the interactors [70, 72, 74]. CircRNAs can exhibit anticancer effects: as
synthetic circular sponges displayed superior anticancer activities compared with
the linear sponges, RNA circles open new ways to deliver miRNA sponges with
persistent effects [34].
CircRNAs like linear isoforms can act as competing endogenous RNAs (ceR-
NAs) that decoy miRNAs and indirectly regulate protein-coding gene expression
(Figure 1.4) [75]. ceRNAs are implied in the progression of cancer and impact on
cancer hallmarks [69]. Being resistant to miRNA-mediated degradation circRNA
can presumably also tether RISC components depriving the cellular pool of both
miRNAs and RISC effectors [70].
Following the observations of circRNAs acting as ceRNAs it has been asserted that
such a mechanism may be common to all circRNAs. The latter finds support from
previously mentioned shortage of polymorphisms in circRNAs’ putative miRNA-
binding sites. Other studies showed instead that only a minority of expressed
circRNAs present multiple binding sites for specific miRNAs and according to their
observations circRNAs are, in general, not bound to miRNA-loaded Argonaute
proteins [44, 76]. In addition, argonaute co-immunoprecipitation experiments did
not indicate an appreciable enrichment of circRNA-derived exons among argonaute
family-bound transcripts, which would be expected if circRNAs were prevalently
acting as ceRNAs. See Thomson & Dinger [77] for a review on evidences and open
questions on endogenous miRNA sponges. According to available data, supported
by recent findings [11, 72] we conclude that some circRNAs can act as ceRNAs,
whereas others may be involved in a variety of other molecular mechanisms.
Interactions with RBPs The decoy activity of circRNAs could be important
also for RBPs (Figure 1.4). CircRNAs like linear RNAs may interact with RBPs in a
sequence-specific and structural motif determined way. CircRNAs could function
to store, sort or localise RBPs. Recently, the interaction between Foxo3 circular
RNA and specific proteins was shown to delay cell cycle progression [78]. Foxo3
is a forkhead box O transcription factor and may behave as a tumour suppressor
protein that limits cell proliferation and induces apoptosis and is frequently altered
in cancer, shown to be deleted in lymphomas (diffuse large B-cell lymphoma) and
translocated withMLL in leukaemia [79]. In healthy cells high circ-Foxo3 expression
12
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Figure 1.6: Circ-Foxo3 dependent mechanism of cell cycle regulation. Circ-Foxo3 plays a
role in the regulation of cell cycle interacting with p21–CDK2 complex. Figure from Du
et al., 2016 [78].
was found to be associated with cell cycle progression. Silencing endogenous
circ-Foxo3 promoted cell proliferation, whereas ectopic expression of circ-Foxo3
repressed cell cycle progression by binding to cell cycle proteins cyclin-dependent
kinase 2 (CDK2) and cyclin-dependent kinase inhibitor 1 (or p21). Normally, CDK2
interacts with cyclin A and cyclin E to facilitate cell cycle entry, while p21 inhibits
these interactions and arrests cell cycle progression. The formation of the circ-
Foxo3–p21–CDK2 ternary complex arrests the function of CDK2 and blocks cell
cycle progression (Figure 1.6). This study identified an oncogenic function of a
circRNA and indirectly demonstrated that circRNAs can have distinct functions
with respect to that of protein products encoded by the same gene [78].
Cis regulation of gene expression by circRNAs Another line of evidence
reported cis-regulatory roles for specific circRNAs. Exon–intron circRNAs derived
from circularisation of RNA with intron retention were identified as a subclass of
ciRNAs, enriched in the nucleus, associated with Pol II [11]. Further analyses of two
exon–intron circRNAs (circEIF3J and circPAIP2) showed interactions with Pol II, U1
snRNP and parental gene promoters through sequence complementarity between
the U1 snRNA and an U1-binding site, which eventually promote the transcription
of the gene from which they derived (host genes), triggering a positive-feedback
loop (Figure 1.7).
Zhang et al. [12] described circular intronic RNAs (ciRNAs) that were found
to accumulate in human cells due to a failure in debranching and showed that
knock-down of ciRNAs reduced expression of their host genes. One of these abun-
dant RNAs, ci-ankrd52, largely accumulates to its sites of transcription, associates
with the elongation Pol II machinery and acts as a positive regulator of Pol II
transcription [12]. Apparently also non-coding intronic segments of ciRNA tran-
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Figure 1.7: EI-circRNA mechanism of regulation of gene expression. EI-circRNAs interact
with the transcription complex in the nucleus. Figure from Li et al., 2015 [11].
scripts can have a cis-regulatory role. CDR1-as stabilizes CDR1 mRNA expression,
probably with a sense–antisense-based feedback mechanism, where the antisense
circRNA stimulates or stabilises the sense mRNA with subsequent negative impact
on antisense levels [39].
The fairly well-characterized role of circRNAs to positively modulate host gene
expression has foreseeable implications for stability of cell commitment choices
such as in haematopoiesis.
In summary, circRNAs can regulate host gene expression but also participate
to complex networks in which they compete for the binding of miRNAs (ceRNA
networks) of RBPs or even for translation initiation. CircRNAs with different
composition in terms of exon–intron inclusion result in a multitude of mechanisms
that can affect transcriptome and proteome regulation. Through studies of specific
tissues, cell types and conditions the evident versatility of circRNA is expected to
reveal insight in all kinds of cellular processes.
1.2.3 CircRNAs in haematopoietic compartment
RNA-seq analyses showed dynamic expression of circular isoforms independent
of linear transcript dynamics from the same gene [13] and cell- and differentiation
stage-specific expression [10, 21] prompting lines of research that focused on
specific tissues. Knowing that circRNAs interfere in key cellular processes like self-
renewal, proliferation and apoptosis there is growing interest in studying circRNA
in the haematopoietic compartment. In the haematopoietic tissue, pioneering
studies reported circRNA isoforms of key genes such as MLL [33, 80] without
receiving much resonance in the research community, probably due to the reported
low expression of circular isoforms compared with abundant mRNAs encoding
these key transcriptional regulators. In hindsight low expression of circRNAs of
the above transcription factor can be understood from recent observations that in
specific cell types highly expressed genes (in terms of expressed linear isoforms)
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give rise to relatively less circRNA compared with moderately- or low- expressed
genes [13].
CircRNA discovery by RNA-seq in hyperdiploid B-cell precursor ALL and
in sorted normal leukocyte cell populations Aiming to discover new cancer-
specific fusion transcripts in hyperdiploid B-lineage acute lymphoblastic leukaemia,
Salzman et al. [19] exploited RNA-seq and found many transcripts with permutated
exon order, which they called ‘scrambled exons’ and attributed to circularised RNAs.
In five samples of hyperdiploid B-cell precursor acute lymphoblastic leukaemia they
detected hundreds of circRNA transcripts with more than 700 circular isoforms
comprising more than 10% of all transcript isoforms produced from a compara-
ble number of genes. These circRNAs were however not a specific feature of the
leukaemic cells; PCR verified that scrambled exons were also detected in remission
samples of the patients, in HeLa cells and in normal primary human cells. Also in
sorted cells populations, naïve B cells (CD19+), haematopoietic stem cells (CD34+)
and neutrophils, circRNA isoforms expressed by more than 800 genes were identi-
fied, with circRNA expression accounting for more than 10 % of gene expression.
This study showed that a particular gene can produce circRNAs in more than one
leukocyte type, but single replicate-based preliminary estimations suggest quantita-
tive differences among cell types. This first indication that circRNAs are expressed
both in normal and malignant haematopoietic cells informs the number of circRNAs
in immature and lineage-specific blood cells but does not provide a more specific
and useful interpretation of circRNA relevance for haematopoietic cell functions
and pathology. For instance the study reported and validated a few most abundant
transcripts with scrambled exons (ESYT2, FBXW4, CAMSAP1, KIAA0368, CLNS1A,
FAM120A, MAP3K1, ZKSCAN1, MANBA, ZBTB46, NUP54, RARS and MGA) but did
not pay particular attention to circRNAs from numerous genes that are impor-
tant for normal haematopoiesis and present genomic aberrations or deregulated
expression in leukaemia.
In accordance with published data [19] we observed that circRNAs from genes
related to B-cell differentiation and acute lymphoblastic leukaemia (JAK2, PAX5,
IKZF1, ETV6 and EBF1) are prevalently present in hyperdiploid leukaemia compared
with normal leukocytes samples. The latter is likely an underestimation, as only 54
genes were screened and circRNAs supported by only one read were not considered.
The same authors also investigated circRNA expression in 15 different cancer
and non-cancer cell lines, detecting around 47 000 circle-specific splice junctions
from 8500 genes. The validation of 8 candidates confirmed that all were true
circRNAs [10]. The study further specified that highly expressed circRNA showed
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cell-type-specific increase in expression that was not associated to an increase
of the corresponding linear RNA. Notably, among others, the leukaemia cell line
K562 presented the largest number of genes (16 559) with evidence of circular RNA
expression.
A reanalysis of the same data set using the circRNAs detecting tool CIRI [80]
indicated that more universally shared circRNAs tend to have higher expression
levels and verified that the expression patterns of linear transcripts of circRNA-
encoding exons are more similar in cancer cells compared with non-cancer cell
types, whereas cancer cells appear to havemore diverse circRNA expression profiles,
both considering exonic and intronic circRNAs.
Subsequently, a comparison of CD34+, CD19+, neutrophils and HEK293 (human
embryonic kidney cells) considering only a single biological replicate per cell type
(with sequencing depth around 20 million reads per samples) was reported [21].
The study detected 1950 circRNAs of which 939 are exclusively expressed in CD19+
cells, 333 in CD34+, 194 in neutrophils and 60 in HEK293 cells. Nineteen circRNAs
resulted to be shared between these cell types. The emphasis of this study was on
the demonstration that circRNAs are in part cell-type-specific and are expressed in
a developmental stage-related manner.
CircRNAs inwhole-blood samples fromhealthy individuals RNA-seq anal-
ysis of whole-blood samples [5] showed that whole blood was very rich in circRNAs,
comparable to the cerebellum, with consistent data comparing two biological repli-
cates. Also in this study the emphasis laid on the numeric evaluation and the
demonstration that circRNAs are a natural component of the transcriptome. Whole
blood is composed of a gamma of different cell types. Moreover, the plasma compo-
nent may also be a sink for circulating circRNA of non-haematopoietic cell origin
and can be in fact explored for disease biomarkers, as previously proposed for solid
tumours [17]. We cannot exclude that plasma samples could also contain exogenous
RNA. In malaria infection, thousands of very short circRNAs are produced by Plas-
modium falciparum [81], including dozens of circRNAs harbouring more than 100
binding sites for a given human miRNA, pointing to highly versatile parasite–host
interactions. Similarly, as already proposed for virus–host interactions, circRNAs
of viral origin might sponge host miRNAs and vice versa [42].
CircRNAs in platelets Alhasan et al. [82] reported circRNA enrichment in plate-
lets that they ascribed mainly to differential decay of linear RNA, considering the
particular circRNA resistance to degradation. In the past integration of transcrip-
tome and proteome data of platelets had given somewhat conflicting results [83].
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Extensive degradation of linear RNA isoforms leaving circRNAs intact, which
results in an extensive reduction of the translatable RNAs provides now a straight-
forward explanation for this apparent disparity. This study demonstrated that
circRNAs are highly enriched not only in platelets but also in erythrocytes relative
to nucleated cells finding that more than 3000 genes show 17- to 188-fold relative
enrichment of circRNAs.
1.2.4 Fusion-circRNAs
Fusion-circRNAdiscovery Very recently fusion-circRNAs (f-circRNAs) derived
from transcribed exons of chimeric genes generated by cancer-associated chromoso-
mal translocation were discovered and proven to be oncogenic according to in vitro
and in vivo experiments [84] (Figure 1.8). Instead of a discovery-driven approach this
study used informed guessing to directly detect transcript circularisation around the
breakpoint/fusion region of two well-known recurrent leukaemia-related transloca-
tions. The authors hypothesized that juxtaposition of complementary sequences in
introns at either side of the fusion regions could favour the formation of circRNAs
and searched specifically for circRNAs expressed from fusion genes. f-circRNAs
were thus detected by RT-PCR and then confirmed using RNA-seq and custom
bioinformatics procedures, in promyelocytic leukaemia with a PML/RARα and acute
myeloid leukaemia with anMLL/AF9 fusion (Figure 1.8A). Both translocations gave
rise to more than one f-circRNA characterized by different backsplice junctions,
both in patient samples and in patient- derived cell lines. The discovery was also
extended to solid tumours showing f-circRNAs transcription in translocated Ewing
sarcoma and lung cancer.
F-circRNAs are proto-oncogenic and a requisite for leukaemic cells viabil-
ity Guarnerio et al. [84] showed that f-circRNAs (f-circPR and f-circM9) expression
in leukaemic cells increases cell proliferation and clonogenicity and that f-circRNA
silencing reverted the phenotype, demonstrating that these f-circRNAs are biologi-
cally active and exert pro-proliferative and proto-oncogenic activities (Figure 1.8B).
Moreover, shRNA-based knock-down of f-circM9 in leukaemic THP1 cells resulted
in increased apoptosis showing that f-circRNAs have an important role in main-
taining the viability of leukaemic cells.
In vivo study of f-circRNAs Human leukaemic cells expressing f-circRNAs in
vivo sustain disease progression in mouse. On the other hand, f-circRNAs alone
did not trigger leukaemia. Cells expressing f-circM9 together with the MLL/AF9
fusion protein have an increased ability to proliferate and form colonies than cells
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Figure 1.8: F-circRNAs derived from chromosomal translocations have oncogenic role. (A)
Transcription of fusion genes generated by cancer-associated chromosomal translo-
cation could generate both linear mRNA coding for oncogenic fusion proteins and
f-circRNAs [84]. The figure depicts the example of f-circM9_1 expressed in cells harbour-
ing the well-known acute myeloid leukaemiaMLL/AF9 t(9;11)) translocation: f-circM9_1
includes two sequences not present in the normal genome, the MLL exon 8 and AF9
exon 6 fusion junction derived from the chromosomal translocation and the backsplice
junction connecting MLL exon 7 with AF9 exon 6. (B) f-circM9 was demonstrated to
be proto-oncogenic in vitro (increasing proliferation rate and foci forming ability in
mouse embryonic fibroblasts, MEF) and required for leukaemic cell (THP1) viability.
f-circM9 alone resulted not sufficient to trigger leukaemia in vivo when expressed in HSC
xenografted in mice. Concurrent expression of f-circM9 and MLL/AF9 fusion protein
contributed to leukaemia progression in vivo and ex vivo cells expressing f-circM9 and
MLL/AF9 displayed increased ability to proliferate and to form colonies. Furthermore,
f-circM9 expression inMLL/AF9 mouse model cells increased the resistance to leukaemia
treatments suggesting that f-circM9 impacts to pre-clinical therapeutic outcome.
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expressing the fusion protein alone, strengthening the hypothesis that f-circRNAs
contribute to the leukaemogenic process in vivo (Figure 1.8B). Human leukaemic
cells in vivo expressing f-circRNAs sustain disease progression in mouse. Moreover,
f-circRNAs expression could provide tumour cells protection to standard leukaemia
treatment, as arsenic trioxide, and confer survival advantage to leukaemic cells
in response in addition to standard-of-care leukaemia treatment with cytarabine.
Thus, according to these experiments in a pre-clinical setting f-circM9 could impact
therapeutic outcomes.
Interestingly, Guarnerio et al. [84] argued that the latency of leukaemia devel-
opment in animal models could be due to the absence of f-circRNAs in modelled
expression of intron-less fusion genes. Even if it does provide neither data nor
hypotheses on the mechanisms underlying the observed pathogenetic effect of
f-circRNA, the study [84] is a breakthrough for leukaemia research. In addition,
as noticed by the authors, not only the expression of f-circRNA but also the re-
duction of circRNAs expressed from the non-translocated allele partner genes can
contribute to the pathogenic effect.
1.3 Detection of circRNAs from RNA-seq:
bioinformatics challenges and approaches
Bioinformatics is an essential part of circRNAs analysis, since the approach of
detecting their presence in a transcriptome-wide manner produces a very large
amount of data to be handled. The high throughput of next generation sequencing
techniques has been recognized as one of the major advantages of this approach,
but at the same time confronted scientists with the question of how to deal with the
large size of the data output. Bioinformatics developed techniques to disentangle
and polish the raw data first and then to extract reliable information from them,
both concerning the identification of molecules and the quantification of their levels
of expression.
In the case of circRNAs the standard analysis techniques used to handle RNA-
seq data needed to be adapted to be able to identify the backsplice junction reads.
CircRNAs can be detected thanks to the presence of this particular splicing junction,
that would not occur if the molecule were not circular. In fact, reads that map
on the exons involved in the circularisation, but not spanning the backsplicing
junction, can be aligned both on the circular and on the linear form. That being the
case these reads cannot be used to detect circRNAs.
In the past reads mapping to the reference genome with non-collinear exon
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junctions were often considered artefacts and discarded; with the rise of interest in
fusion transcripts produced from rearranged genomes, trans-splicing and circRNAs,
RNA-seq aligners were adapted to consider also these ‘exotic’ events. In those
reads, parts of the transcript sequence correspond to regions that are remote in the
reference genome (fusion and trans-spliced transcripts) or that map to the genome
in a chiastic way (that is, two segments of a single read align separately in reverse
order due to the backsplicing in circRNA biogenesis; see also Figure 1.2B).
Table 1.1 presents ten computational methods that allow backsplice events iden-
tification using different strategies and read aligners; some approaches are specific
to predict circRNAs, whereas others were developed with more general purposes,
such as read alignment and/or detection of fusion events, and allow also circRNAs
detection. For each method, the table indicates the read aligners and number of
mapping steps implemented in the prediction strategy. It also clarifies whether the
method requires genome annotations in input and if it provides an annotation of
predicted backsplice junctions in terms of overlapping genes. Finally it is described
whether the tools has been designed explicitly for circRNA identification or if they
are more general purpose software and the last two columns report additional notes
on specific software features and references. Recently, five circRNA prediction tools
(circRNA_finder, Find_circ, CIRCexplorer, CIRI and MapSplice) have been com-
pared by evaluating the levels of true- and false-positive circRNAs based on RNAse
R resistance data, showing that not in all cases the most abundant circRNAs are
true positives, that circRNAs identified by a single method only are in general less
reliable and that the combination of at least two methods increases specificity [85].
1.4 Open questions and challenges regarding
circRNAs in haematopoiesis
CircRNA expression further challenges a simplistic definition of ‘gene’, reinforc-
ing the concept that genes are complex transcriptional units and that the sequence
of a given genomic region is a sort of palimpsest1 that contains multiple, interleaved
and overlapping information parcels [90]. Transcripts from the same locus use a
common sequence in different ways and perform distinct biological roles. In addi-
tion, circRNAs add new hints to our understanding of the alternative use and reuse
of RNA sequences to produce different products and even small RNAs, as known
in the case of miRtrons [91] and of tRNA- or snoRNA-derived miRNAs [90, 92] and
moRNAs [93–95], that are expressed in blood cells [94, 95] and were shown to have
1A palimpsest is an ancient parchment on which the original text was overwritten multiple times.
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pathogenic relevance in B-cell lymphomas [96]. Ultimately gene expression studies
need to disentangle the expression of linear and circular RNAs expressed from each
locus in order to dissect the distinct or complementary processes in which they
participate.
A large body of data regarding molecular circuits that control cellular differentia-
tion of the haematopoietic system is available and its deregulation in malignancies
in association with genomic lesions is increasingly understood. In haematopoiesis,
differentiated cell states are controlled by densely interconnected transcriptional
circuits [97] in a seemingly hierarchical process of binary fate decisions, but the
stiffness of cell fate may be more fluid [98] allowing for epigenetic regulation
in response to mature blood cell demand. We envisage that circRNAs studies of
haematopoietic cell stages will further elucidate how cell fate fluidity may depend
on stably present circRNAs of key cell stage mRNAs.
Gene expression profiling of the protein-coding transcriptome has been very
useful for the study of haematopoietic malignancies but will become more com-
plete when integrated with circRNA expression data. Among other things it can
be expected to elucidate discordant gene-protein expression often revealed for
marker proteins of haematopoietic cell stages (for example, CD10, CD22 and CD38).
Furthermore, induced pluripotent stem cell modelling of haematopoietic diseases
may also benefit from circRNA studies, hitherto nothing is known about the be-
haviour of circRNAs in reprogramming procedures of induced pluripotent stem
cell generation.
Recent RNA-seq data outlined transcriptional diversity in terms of (linear) alterna-
tive isoform-ratio variations among haematopoietic cells [3, 99] and of non-coding
RNA’s impact in haematopoietic lineage differentiation [100]. Specific miRNAs are
expressed in a developmental-stage-specific manner [101, 102]. miRNAs and other
small RNAs are differentially expressed in disease [95].
As in last years we abandoned the concept of the centrality of coding fraction of
the transcriptome, the discovery of circRNAs made clear that the study of the linear
RNAs only provides an incomplete picture of the cellular complexity. Focusing on
linear transcription only we miss important elements, both for data interpretation
and experimental design.
Today we have an increased appreciation of circRNA abundance, evolutionary
conservation and diversity of functions and interactions. Specific data emerged
of high and regulated circRNA expression in normal and malignant blood cells.
The recent discovery and functional study of f-circRNAs provided important clues
of the oncogenic role of this aberrant circRNA in leukaemogenesis and of their
relevance in modulating therapeutic outcome. Together these data clearly indicate
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that further studies of circular isoforms from different cell types and stages of the
haematopoietic compartment and by rearranged or mutated genomes are warranted
to better estimate the position of these new regulators in haematopoietic cell
development and derived malignancies. The route toward elucidating circRNA
biology is still long. Even a consistent nomenclature for circRNAs is sorely missed.
Definitely, circRNAs and their diverse molecular interactions participate to the
circuitries that regulate the final cellular protein output adding to the richness and
complexity of the underlying mechanisms. The particular stability of circRNAs
may also make them valuable disease markers that can be identified in various
body fluids and we envisage that a better understanding of circRNA biology will
inform innovative therapeutic targets.
1.5 Aim of the research
The aim of the research is to expand the knowledge of the transcriptional land-
scape of normal andmalignant haematopoiesis to shed new light on themechanisms
underlying molecular circuits. Since circularisation can compete with mRNA splic-
ing favouring exon skipping, alternative splicing deregulation impacts specifically
on disease course in leukaemias and myeloproliferative neoplasms, and somatic
mutations of splicing factors are frequent in haematological malignancies, we hy-
pothesize that circRNA expression might be linked to aberrant splicing patterns,
with effects on the proteome and on the non-coding transcriptome as well. We
aim to identify qualitative and quantitative specificities of circRNAs in normal
haematopoiesis, that will be subsequently validated. The knowledge of circRNAs
in normal haematopoiesis will be precious to better understand regulatory circuits
and aberrant functions in blood malignancies and other diseases. Actually the
simple discovery and initial characterization of circRNAs is not sufficient to obtain
a significant advance on functional knowledge. We envisage that predictions of
circRNA functions and interactions will facilitate the prioritization of candidate
circRNAs for functional investigation.
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The detection of circRNAs in RNA-seq data is performed by identifying reads
containing a backsplice junction. In the classical analyses of RNA-seq data, reads
that contain backsplice junctions are discarded because they can not be mapped on
the reference transcriptome. Next generation sequencing has revived the interest in
circRNAs, so algorithms written specifically for circRNAs detection from RNA-seq
data were needed, and various tools with different approaches to the detection have
been published.
In collaborationwith dr. Enrico Gaffo and prof. Stefania Bortoluzzi (Department of
MolecularMedicine, University of Padova), we built up circPipeline, a computational
pipeline to perform the detection and analysis of circRNAs (and linear RNAs) from
RNA-seq data. A simplified and refined version of the circPipeline, that performs
circRNAs analysis, has been described in the paper “CirComPara: a multi-method
comparative bioinformatics pipeline to detect and study circRNAs from RNA-seq
data” by Gaffo E. et al. (in press Journal Non-coding RNA). This pipeline is available
at https://github.com/egaffo/CirComPara.
Amongst tools and methods listed in Table 1.1, Find_circ and Testrealign, and
then CIRI were available at the beginning of our project hence were initially used
for our analyses. In particular Find_circ was developed by Memczak and colleagues,
who were the first to study circRNAs using next generation sequencing data. Testre-
align has an interesting feature that circRNAs detection is implemented inside the
mapping algorithm. CIRI uses a different detection algorithm compared to Find_circ
and Testrealign, and in particular pays attention to false positive filtering. Thanks
to the modularity of the pipeline, we were later on able to add another program,
CIRCexplorer. The latter program was analysed by Hansen et al. in 2015. These
authors compared several available methods for circRNAs detection to analyse their
performance, also in combination with each others. Their analysis in fact high-
lighted that CIRCexplorer, combined with any other program allowed to perform
the best false positive filtering.
2.1 Algorithms description
The algorithms used in the different programs can be divided in twomajor groups,
those working de novo and those needing an annotation of the reference genome
and transcriptome. De novo algorithms perform backsplice detection basing on
intrinsic features of the sequencing reads, thus allowing to find circRNAs deriving
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also from non annotated regions. Algorithms that need an annotation can only
identify circRNAs that belong to known exons and introns, and therefore are
expected to be more conservative in their results. All programs need as an input
the reads aligned to the reference genome by a specific reads aligner to obtain files
compatible to their algorithm.
2.1.1 CIRI
CIRI requires as input the FASTA file of the reference genome used for the
alignment and the aligned reads in SAM format generated by BWA-Mem.
The circRNAs detection by CIRI is based on the recognition of the PCC signal
(Paired Chiastic Clipping) which is encoded in the CIGAR string of the alignment.
The CIGAR string is an alphanumeric description of the mapping of each read to
the reference genome, in which every letter has a specific meaning, such as M for
matched, D for deletion and so on. When one read is split to be aligned in two
separate places of the genome it appears two times in the SAM file, once for the
first part of the alignment and once for the second portion aligned. The unaligned
portion in these two records is marked as ‘clipped’ in the CIGAR string with S or H.
CIRI’s first step is to retrieve the reads that display the PCC signal: the same read
repeated with a CIGAR string similar to MxSy in the first occurrence and SxMy in the
second one.1 When CIRI detects such a signal it then checks the strand information
and the mapping position in the SAM alignment. If the two segments align on the
same strand of the same chromosome and within a reasonable distance (basing on
the actual distance of the mate-pair) the read is considered as a candidate junction
read with positive PCC signal. CIRI then uses the additional information provided
by the mate-pair layout to preliminarily filter the false positive PCC signals: a
candidate PCC-harbouring read passes the filter only if its paired read aligns within
the region of the putative circRNA range. This is a procedure only carried out if
the reads are mate-paired. Apart from this CIRI also uses the reference genome to
refine the list of putative circRNAs by checking if the AG and GT dinucleotides of
the canonical splicing sites actually flank the individuated backsplicing junction.
The program also accepts a list of other non-canonical splicing sites to complement
the filter of false positive circRNAs. Once filtered for the false positives, CIRI scans
the alignment file a second time to perform a thorough investigation of the putative
junctions that passed the filtering. In this step CIRI summarizes the mapping
positions of the different reads related to a certain candidate junction, compares
the counts and the mapping lengths, thus determining if the reads reliably reflect
1For the first occurrence of the read x is the number of matched bases (M) and y is the number of
clipped bases (S) and vice versa for the second occurrence.
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a circRNA junction and if it should be kept in the final output. At the end of the
run the output consists of a SAM-like file with information on the number of reads
covering a certain junction, on the number of mate-reads that are coherent with
each putative junction, and with a simple genomic annotation.
2.1.2 CIRCexplorer
CIRCexplorer is the circRNAs-detecting tool described in the 2014 paper by
Zhang et al. [103]. Sequence reads from each sample are first mapped using TopHat,
and unmapped reads are then extracted and mapped onto the reference genome
using TopHat-Fusion. Reads that split and align on the same chromosome but
in non-collinear order (indicated with special XF tags in output BAM files) are
extracted as candidate backspliced junction reads. Backspliced junction reads are
then further realigned against existing gene annotations to determine the precise
positions of donor or acceptor splice site for each backspliced event. Junction reads
with shifted alignments against canonical splice sites (with the consensus sequence
flanking the donor splice site and the acceptor splice site) are adjusted to the correct
positions, and reads with alignments on different genes or non-canonical splice
sites (largely arising from trans-splicing or PCR errors) are discarded. Finally, the
remaining backspliced junction reads are combined and scaled to RPM (Reads Per
Million) mapped reads to quantify each backspliced event. The output is a BED-like
file with information on the read counts for each junction and the annotation.
2.1.3 Find_circ
The Find_circ tool is described in the paper by Memczak et al., 2013 [21]. The first
step requires the sequencing reads to be aligned with Bowtie to filter out the reads
that align contiguously and fully to the reference genome. Then the unmapped
reads are passed to Find_circ for circRNAs detection, which is the strategy we
decided to use in our pipeline too. The tool extracts 20mers from both ends of the
read and aligns them independently to establish their unique anchor position on
the reference genome. Only anchors that align with reversed orientation (head-
to-tail) allow to detect a putative circular junction. Once established the anchor
positions, the 20mers are extended so that the whole read aligns and the break
point is flanked by GU–AG splicing sites. Before finalizing the output the putative
backsplice junctions undergo a quality filtering step to increase the robustness of
the results. Among the filters applied by Find_circ is the requirement of at least
2 reads covering a certain backsplice junction, that the distance between the two
ends of the junction is not longer than 100 kb and an high quality alignment of
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the reads (unique mapping of the anchors and not more than two mistakes in the
extension procedure). Find_circ outputs the detected splicing junctions in a BED
format file with additional fields containing quality statistics and reads counts.
2.1.4 Testrealign
CircRNAs detection by Testrealign is based on mapping seeds identified by the
aligner Segemehl [104]. Because of the structure of the spliced read, a semi-global
alignment is likely to fail, while the method used by Segemehl will identify several
seeds matching different locations. The algorithm used, which is able to identify
both splicing events (normal, trans-splicing and backsplicing) and gene fusion
sites, is based on a greedy seed chaining followed by a Smith–Waterman-like
alignment. The final output of Testrealign is a BED file containing both normal
splicing, trans-splicing and circular splicing events.
2.2 circPipeline: a pipeline for detection and
analysis of circRNAs from RNA-seq data
The pipeline (Figure 2.1) puts together both published tools and custom scripts.
It is modular and extensible, and most importantly it is automated in many of its
branches, to decrease human errors, speed up the analyses and allow re-analysis
using different settings.
The pipeline is divided in two main sections: the detection module and the
analysis module. The first one performs the reads alignment and annotation,
starting from the raw reads produced by the sequencer, and is fully automated.
Among the several tools for circRNA detection published in the last few years, we
used the four described in Section 2.1. The results are then fed to the second section
that performs the sequence reconstruction and expression levels quantification,
and is partly automated to allow specific analyses decided by the operator.
In parallel to the circRNAs analyses the pipeline also performs the classical
RNA-seq analyses for the comparison of the expression levels of linear and circular
transcripts.
The raw sequencing reads are preliminarily aligned by HISAT2 that produces
two separate files, one with the reads mapped on the reference genome and one
with the unmapped reads. The first one is passed to the linear pipeline, while
the second is used by the circular pipeline (Figure 2.2). This choice was made to
decrease the computational burden of the alignment step of the pipeline and to
increase the retrieval power of the circRNA-detecting programs. In this way the set
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Figure 2.1: Architecture of the pipeline for circRNA and linear RNA analysis. The purple
section indicates the preparation of the data, the blue section indicates the detection
module of the pipeline and the yellow section indicates the analysis module, in orange
the final output of the pipeline.
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Figure 2.2: Before linear and circular RNA detection, a preliminary alignment step is per-
formed to sort out reads aligning collinearly to the reference genome, to be used for
linear transcriptome reconstruction, and reads not mapping, to be used for backsplice
and circRNA detection.
of the reads is aligned only once to discriminate between mapped and unmapped
reads, with relaxed filters. The subsequent alignment of the unmapped reads with
parameters suitable for backsplice detection is performed on a smaller amount of
reads with lower background noise in the alignment.
2.2.1 Linear pipeline
The preliminary alignment performed with HISAT2 produces a file containing
mapped reads that is used by the ‘linear pipeline’ for the standard RNA-seq anal-
yses on linear transcripts. The reconstruction of the sequence is performed by
Cufflinks2 [105], which produces a list of transcripts containing various isoforms,
and for each of them an expression level is calculated. The transcripts are associ-
ated to the gene of origin. The final step of the linear pipeline is the differential
expression analysis.
2.3 circPipeline: detection module
The detection of the circRNAs is performed independently by the four different
programs in parallel (Figure 2.3). The unmapped reads input to the pipeline are
aligned by four different aligners (STAR, BWA, Bowtie and Segemehl), as each
circRNA-detecting program requires a specific aligner in order to have a specific
file format. Each aligner passes the mapped reads to the corresponding program for
the detection of the putative circRNAs. The algorithms of the four chosen programs
are described in section 2.1. The usage of four different programs increases the
detection power and allows the possibility of a false positive filtering, by overlapping
the four results. The output of each program is a file with different formats (one for
each analysed sample), thus for the downstream comparisons only the fields that
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Figure 2.3: The detection module of the circPipeline. The left branch regards circular RNAs
detection, in which the reads are alligned in parallel by four different reads aligners, and
then processed by the relative circRNA detection tool; after that the results are filtered
for false positives and annotated by custom scripts. The right side regards the linear
branch of the pipeline, in which the reads are aligned for linear transcripts detection.
are common to all the files are maintained, such as the position of the backsplice
and read counts.
The putative circRNAs are preliminarily filtered on the level of expression, keep-
ing only those detected by at least two sequencing reads, as suggested previ-
ously [16], which is a technical filter to decrease the number of false positive results.
The latter also has the effect of conforming the results to those of CIRI and Find_circ,
which already have this filter implemented in their algorithm. We decided to put
another technical filter on the length of the distance of the backsplice junction,
to keep only circRNAs longer than 200 nucleotides. It has to be noted that exons
shorter than 200 nucleotides do actually exist; this filter though was suggested by
the work of Hansen et al. [85], as they pointed out that circRNAs shorter than 200
nucleotides were more likely to be false positives.
During the pipeline development we decided to overlap the results of the four
used programs. The above mentioned article of Hansen et al. [85], in which they
report five circRNA-detecting programs for specificity and sensibility, supports the
validity of our choice. For their study they sequenced the RNA of four samples of
human fibroblasts in two conditions each: one with only ribosomal RNA depletion
and one with the addition of the RNAse R treatment before library preparation,
which only digests linear molecules. The comparison of the circRNAs found in
the two conditions gives a measure of how specific and sensitive each program
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is. To perform this analysis the circRNAs are classified as ‘enriched’ if the fold
change is greater than 5 in the treated samples, ‘unchanged’ if the expression level
is unaffected by the treatment (fold change between −5 and 5), and ‘depleted’ if the
fold change is lower than −5 in treated samples. They showed that some programs
were more specific or sensitive than others, and most of all that using at least two
programs together significantly lowered the false positive rate. This was measured
by counting the number of circRNAs that were detected in the untreated samples
and that could not be found in RNAse R treated samples, meaning that they were
mistakenly indicated as circRNAs.
To allow the comparison between the four methods, the starting position of
the backsplice had to be corrected for CIRI and Testrealign, where the output
is ‘1-based’, meaning that the first base is numbered as 1, while Find_circ and
CIRCexplorer produce a ‘0-based’ output, meaning that the first base is numbered
as 0. We chose to subtract 1 to the starting base of the backsplice junction for CIRI
and Testrealign, according to Hansen et al. [85].
Finally, to guarantee a higher robustness of the dataset we decided to select only
putative circRNAs that were detected at least by two of the four programs used.
Together with the detection, some programs (CIRI and CIRCexplorer) do perform
a simple annotation step, but we added a custom script in R to allow a more detailed
annotation, indicating, among other information, the gene of origin and information
regarding circRNA composition (exonic, intronic or intergenic).
The filtering and annotation of the circRNAs is performed with custom R scripts.
The first branch of the pipeline produces two files: a list of circRNAs identified
by a unique key (built up as follows: chr:start|stop:strand) and a matrix with
the expression levels of all detected circRNAs of all analysed samples. For each
putative circRNA in the list we know the starting and final position of the backsplice
junction on the chromosome, the strand, the number of reads detecting the specific
backsplice junction, the genomic feature of the involved sequences and the gene of
origin, the programs that detected it, the sample and cell type in which they were
retrieved.
2.4 circPipeline: analysis module
The output matrix of the first branch is then used by the second branch of the
pipeline (Figure 2.4) to perform the analyses on the sequence and expression levels
of the putative circRNAs.
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Figure 2.4: The analysis module of the circPipeline. The left side regards the branch for
circRNAs analysis, that performs circRNAs sequence reconstruction and circRNAs
expression levels analysis. The right side regards the linear branch of the pipeline, in
which linear transcript reconstruction and expression level analysis are performed. In
the and the information produced by the two branches is compared and integrated.
2.4.1 Sequence reconstruction
Sequence reconstruction can not be easily done for circRNAs because the only
reads undoubtedly ascribable to circRNAs are those harbouring the backsplice
junction. Other reads, deriving from the inner part of the molecule, such as those
mapping completely on an exon or an intron can be equally attributed to the linear
and circular isoform of that sequence. These are preliminarily mapped by HISAT2
to the reference genome, thus being fed to the linear pipeline and not to the circular
pipeline.
The information available for each putative circRNA allows to know that the
genomic features on which the two ends of the backsplice map are present in the
circularized molecule. However, we cannot know if exons or introns included in
the interested genomic region are actually present in the circularised molecule or if
they have been excised. We can hypothesise that at least the features identified by
the mapping are actually present, so at least that sequence can be inferred and used
for downstream functional prediction. For example this is the case of a backsplicing
junction involving a single exon or a single intron, which probably belongs to a
mono-exonic circRNA or to a mono-intronic circRNA. Up to now the only accepted
method to know the actual sequence of a circRNA is by Northern blotting after
RNAse R digestion — using a probe that hybridises to the backsplice junction —
that allows to know its actual length, and then to sequence it.
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2.4.2 Expression levels and differential expression analysis
The amount of reads harbouring the backsplice junction is the most trustworthy
measurement of expression level of a circRNA according to the current literature
on the subject. The pipeline produces up to four different levels of expression for
each circRNA in each sample. The raw reads counts are then normalized for each
sample and for each program on the total number of reads mapped, to compare the
results of the four programs. The expression level is then calculated as the median
value of the normalized levels of expression detected by each program. The choice
of using the median is dictated by the higher robustness of this value compared to
the mean. The normalization and calculation of the median value are performed
by custom R scripts. Once the expression level for each circRNA in each sample is
defined, other custom R scripts are used to perform cluster analysis if requested for
the specific experiment.
Once the expression levels are established, they are used to perform differential
expression analyses using R, in particular with the package DESeq2 [106], to identify
circRNAs and linear RNAs upregulated or downregulated amongst the different
sample classes.
2.5 Discussion and conclusions
The first branch of the pipeline is fully automated and thanks to its modularity it
can be expanded to add new programs for the detection of circRNAs, thus allowing
to constantly keep up to date with the best and newest algorithms for circRNA
retrieval.
The sequence reconstruction portion of the pipeline lags behind in performance
to reliably infer the actual structure of the various circular molecules. Longer
sequencing reads may be of use to overcome this issue.
Our pipeline performs expression level analysis for circRNAs considering the
reads spanning the backsplice junction. The reads which belong to an internal
portion of a circRNA, thus not harbouring the backsplicing junction, are originally
mapped on the linear transcriptome. This produces a bias on the calculation of
the actual expression level of the linear isoform. To overcome this issue we will
implement a re-tuning of the expression level of those molecules basing on the
expression level of the circular form and on the unbalance of the expression levels
between the exons of the linear transcript.
CIRI provides also an extra useful information thanks to its ability to utilise the
paired-end layout of the sequencing, which could be useful for a future improvement
of the pipeline: its output contains in fact a field in which the number of mate-reads
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mapping on a sequence compatible with a circular molecule is counted; for example
the second read maps on the second of the two implicated exons. This piece of
information might be of use to further refine both the quantification of circRNAs
expression levels and the molecular structure. It may be useful to implement this
kind of analysis irrespective of the program that detected the circRNAs.
Re-tuning the expression levels of both linear and circular isoforms will allow to
improve the quality of the comparison between them, which is important informa-
tion to be retrieved to speculate on circRNAs functions.
2.5.1 Perspectives
The putative circRNAs output of the pipeline can be used for functional predic-
tions based on the retrieval of specific sequence motifs, such as those for RNA–RNA
or RNA–protein interactions. These analyses have to be performed knowing the
sequence of the molecule. An automated and dataset-wide analysis would be to
search for sequence motifs in the reads spanning the backsplicing junction, as
those hundred bases are the only actually available sequence. Exonic sequences
are known to harbour different binding sites, like those for miRNAs, RNA-binding
proteins, other RNAs; but it is of particular interest whether the new sequence
produced by the backsplice junction creates a new motif or binding site.
Instead, for circRNAs with completely available sequence, such as the ones
sequenced or those for which the sequence is inferred based on their putative
structure, more in depth analyses can be performed. Internal ribosome binding sites
(IRES) can be detected and the coding potential can be tested as well, for example
by translating the circRNAs on all putative frames, to see if a looping protein or
an entirely different polypeptidic chain from a well known coding exon could be
expressed.
This pipeline allows to perform a fast analysis of the transcriptome in a refined
fashion, by adding the analysis of the circRNA-ome that was up to now left behind
in most of the published transcriptome studies. This will definitely allow the
production of more reliable results in exploratory studies such as the linear-only
RNA-seq studies, which will result in more complete and useful information when
turning to functional studies.
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3 Pilot study of circRNA expressed
in lineage commitment of
human blood progenitors
This chapter deals with a pilot study for circRNAs detection and quantification
using publicly available RNA-seq data obtained with a polyA enrichment protocol.
The RNA-seq data EGAS00001000284 were originally obtained by Chen et al. (2014)
and used in a study focused on gene expression programs driving or associated to
lineage choices in haematopoietic cells differentiation [3], in a study focused on
linear transcripts and linear isoforms expressed.
The dataset contains RNA-seq data from eight primary human haematopoietic
progenitor populations representing the major myeloid commitment stages and the
main lymphoid stage. In the original study Chen et al. identified cell-type-specific
expression changes and classified differential expression patterns during lineage
commitment. They described that each cell type also has a specific set of transcripts,
with an over-representation of non-coding transcripts in stem cells compared to
the over-representation of coding transcripts in more differentiated cells. More-
over, they highlighted that alternative splicing regulation is widely spread in key
commitment stages. They reported at least 2000 differential alternative splicing
events being significantly enriched in genes involved in regulatory processes. The
study also highlighted the complexity of fating events in the progenitor popula-
tions, in terms of transcripts expression, but did not consider the existence of the
circRNAs. This scholar study thus missed relevant information. Even if these data
were originally obtained to study linear transcriptome and are polyA enriched, we
were able to detect and analyse circRNAs from their RNA-seq data.
During the development of the circRNA pipeline we searched for a publicly
available datasets to test the pipeline and to obtain preliminary results on the
number of circRNA expressed by different cell types in the haematopoietic lineage.
We selected the RNA-seq dataset published in 2014 by Chen et al. (from now on
‘Lineage Commitment dataset’) regarding haematopoiesis.
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Figure 3.1: The cell populations of the haematopoietic tree analysed with RNA-seq se-
quenced by Chen et al., 2014 [3].
3.1 Materials: description of the Lineage
Commitment RNA-seq dataset
The Lineage Commitment dataset covers eight different cell types from the
haematopoietic lineage, from stem cells to lineage restricted progenitor and to termi-
nally differentiated cells: Haematopoietic Stem Cells (HSC), Multi Potent Progenitor
cells (MPP), Common Lymphoid Progenitor cells (CLP), Common Myeloid Progeni-
tor cells (CMP), Granulocyte–Monocyte Progenitor cells (GMP), Megakaryocyte–
Erythroblast Progenitor cells (MEP), Megakaryocytes (MK) and Erythroblasts (EB)
(Figure 3.1). For each cell type there are at least three biological replicates; further-
more for some samples also technical replicates are available. In the original study
HSCs, MPPs, CLPs, CMPs, GMPs and MEPs were sorted from cord blood derived
CD34+ cells. MKs and EBs were obtained by in vitro differentiation of CD34+ cells
derived from cord blood, with thrombopoietin and erythropoietin respectively.
TRIzol™ was used to extract total RNA from the samples; 100 pg of RNA were
used to generate polyA+ RNA libraries with the SMARTer Ultra Low RNA and
Advantage 2 PCR kits. The sequencing was performed on Illumina® HiSeq2000
instruments with TruSeq reagents, to obtain paired end reads 100 bp long. The
layout of the dataset in terms of biological and technical replicates is summarised
in Table 3.1 together with the number of reads sequenced and uniquely mapped.
Lineage Commitment dataset provides information on different cell types and
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Biological replicates Technical replicates
Cell type Sample id Unique reads Sample id Unique reads
HSC
EGAN00001076170 278 126 560 EGAN00001095876_a 39 116 780
EGAN00001068102 237 594 734 EGAN00001095876_b 40 937 346
EGAN00001076149 225 758 528 EGAN00001095876_c 35 254 708
MPP
EGAN00001068106 232 892 714 EGAN00001095875_a 38 460 924
EGAN00001076171 269 943 210 EGAN00001095875_b 40 628 124
EGAN00001095875_c 34 736 660
CLP
EGAN00001076172 278 261 768 EGAN00001095777_a 21 769 286
EGAN00001095777_b 24 012 542
EGAN00001095777_c 25 234 278
EGAN00001096977_a 34 320 484
EGAN00001096977_b 36 059 028
EGAN00001096977_c 31 242 500
CMP
EGAN00001068103 285 898 104
EGAN00001068108 249 276 878
EGAN00001076151 252 893 490
GMP
EGAN00001068104 269 897 054
EGAN00001076152 217 544 690
EGAN00001076173 280 676 782
MEP
EGAN00001068109 233 678 804
EGAN00001076150 278 274 566
EGAN00001068105 257 474 094
EB
EGAN00001095770_a 30 228 364
EGAN00001095770_b 28 677 874
EGAN00001095770_c 31 323 350
EGAN00001095770_d 28 346 756
EGAN00001095771_a 23 854 044
EGAN00001095771_b 22 379 286
EGAN00001095771_c 22 661 582
EGAN00001095772_a 24 828 780
EGAN00001095772_b 26 457 926
EGAN00001095772_c 25 134 586
MK
EGAN00001095842_a 37 761 680
EGAN00001095842_b 40 156 756
EGAN00001095842_c 38 257 390
EGAN00001095825_a 32 698 630
EGAN00001095825_b 34 783 176
EGAN00001095825_c 33 111 900
EGAN00001091941_a 32 493 332
EGAN00001091941_b 34 822 618
EGAN00001091941_c 32 868 522
Table 3.1: Details on the Lineage Commitment dataset in terms of represented cell types,
biological and technical replicates available for each cell type, and sequencing depth
per sample.
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importantly includes several replicates per cell type. The latter feature of replicates
per cell type was crucial for allowing us to develop and test the pipeline usage with
multiple samples classes and biological replicates. Moreover, RNA-seq samples were
obtained with Illumina® technology, thus allowing comparison with the original
data we were producing in the meantime (see Chapter 4), and were sequenced with
high depth (98 million uniquely mapped reads on average). Importantly, CIRI (one
of the programs for circRNA detection used by the pipeline to detect backsplices
and circRNAs) needs the raw input reads to be at least 50 bases long, thus the 100
nucleotides paired-end sequence reads design of the Lineage Commitment dataset
resulted adequate for our purposes. Anyway, optimal RNA-seq data for circRNA
detection are obtained with a library construction method involving ribosomal
depletion but without polyA enrichment, since circRNAs are not polyadenylated.
The main drawback deriving from the choice of this dataset is due to the enrich-
ment method used by the authors of the study: being circRNAs non-polyadenylated
molecules the enrichment on sequences containing a polyA tail would in theory
eliminate circRNAs. In practice the procedure is not 100 % effective thus the dataset
is enriched in polyadenylated transcripts, but other types of RNA molecules, such
as ribosomal RNAs and circRNAs, are still present after the enrichment and thus
are sequenced.
It has to be kept in mind that circRNAs remaining in the sample after the polyA
enrichment are randomly selected, so the most expressed are those with the higher
probability of being carried over. Moreover, it is expected that the most expressed
circRNAs in a cell type would be detected in the higher number of biological
replicates. Furthermore we are fairly confident that if a circRNA is detected, it had
been originally expressed, on the contrary we cannot exclude the possibility of false
negative circRNA detections due to expressed circRNAs that were discarded by
the polyA enrichment step. The pilot analysis we performed with only one of the
four tools (CIRI), to deal with simplified data as our first try on circRNAs analyses,
provided us with useful data to develop the custom scripts needed to handle the
results with R.
In summary, the Lineage Commitment dataset allowed circRNA detection but
limited to a qualitative evaluation of circRNAs isoform expression. The analysis of
this dataset has been useful to test and refine the circRNA pipeline and produced
also original, even though preliminary, results regarding the pervasiveness and the
diversity of circRNA expression in key cell types and stages of the haematopoietic
tree.
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Figure 3.2: Distribution of the frequencies of the number of circular isoforms produced by
each gene.
3.2 Results: circRNAs of the Lineage commitment
RNA-seq dataset
This pilot study was performed with a pipeline version simpler than the definitive
one that is described in Chapter 2, lacking also automated integration of circRNA
detection and annotation results produced by different methods in parallel, that
were implemented later as a series of R scripts.
Here we present a summary of circRNA discovery results grounding on CIRI
method. 11 148 different circRNAs have been detected by CIRI throughout the whole
dataset, expressed by 4317 different genes, meaning that more than one circRNA
is expressed by the same gene of origin. In particular 58 % of the genes produce a
single circRNA, whereas 837 genes (19 % of the total) produce two different circular
isoforms each and 959 (22 %) three or more isoforms each (Figure 3.2).
Technical and biological replicates in the Lineage Commitment dataset
By definition the technical replicates derive from different aliquots of the same
biological sample processed in parallel. In this case enrichment, library preparation
and sequencing were conducted in parallel on the same biological replicates, thus
producing technical replicates useful to analyse the yield of the technical procedure.
The biological replicates of this dataset are samples of a given cell type derived
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from different individuals, informing also on the variability of the expression across
individuals.
In our setting replicates analysis allowed us to explore the repeatability of
circRNA expression from different points of view, considering specific cell pop-
ulations separately, and to start filling a gap in the literature regarding circRNA
expression variability. Most previous circRNA studies were largely discovery-
driven and considered one or a limited number of cell types and, importantly,
grounded on one sample per cell type [13, 19]. Only Memczak et al. in 2015 [5]
compared, although in a quite preliminary way, circRNA expression similarity in
two whole blood samples from healthy individuals. This study showed that out of
4300 unique circRNA candidates detected in each of the two samples at least one
half are supported by at least two reads and are detected in both samples. Moreover,
the expression levels in the two biological replicates were quite similar resulting in
a high (R = 0.80) Spearman correlation between expression levels inter replicates,
not very far from the inter-replicates correlation observed for linear transcripts.
3.2.1 HSC technical replicates analysis
We considered three replicates of the HSC cell population for circRNAs detection.
The three selected technical replicates (EGAN0001095876_a, EGAN0001095876_b,
EGAN0001095876_c) of the HSC sample EGAN0001095876 were sequenced with
average depth of 38 million reads and similar depth (39 116 780, 40 937 346 and
35 254 708 reads) in different replicates (Table 3.1).
In the three technical replicates, 349, 339 and 354 candidate expressed circRNAs
were detected by CIRI, respectively. Classifying circRNAs in exonic, intronic and
intergenic, according to their position with respect to genes and exons annotations,
we observed that the distribution of the types of circRNAs found in the three
replicates are similar (Figure 3.3), as the absolute number of circRNAs falling in
each category is nearly the same in each sample.
This gives a strong indication of the consistency of the results, and it is confirmed
when analysing the overlap of the putative circRNAs found in the three samples.
As shown in the Venn diagram in Figure 3.4, 271 circRNAs are shared by the three
samples, corresponding on average to 63 % of circRNAs expressed in each of them.
Twenty-one percent of circRNAs on average is found in only one sample and the
remaining 16 % is found in two of the three replicates. We speculated that the
circRNAs detected in three technical replicates are the most expressed, those found
only in two are less expressed and the remaining are the least expressed. Anyway,
a fairly good consistency of the detected circRNAs amongst the technical replicates
was observed.
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Figure 3.3: According to annotation of the corresponding genomic regions, detected
circRNAs were classified into exonic, intronic and falling in unannotated (intergenic)
regions; the bar plot shows the abundance of each circRNA class in the three technical
replicates of HSC sample EGAN0001095876.
Figure 3.4: Venn diagram displaying the overlap of putative circRNAs in the three technical
replicates of HSC sample EGAN0001095876.
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Figure 3.5: According to annotation of the corresponding genomic regions, detected
circRNAs were classified into exonic, intronic and falling in unannotated (extragenic)
regions; the bar plot shows the abundance of each circRNA class.
It has to be noted that the technical replicates have a lower sequencing coverage
when compared to the biological replicates. That being the case, and considering
that this analysis highlighted the consistency of the detected circRNAs amongst
the technical replicates, we decided to collapse these replicates into a single sample
to be handled as a single biological replicate. This allows a more meaningful and
informative comparison of the results amongst the biological replicates of the same
cell type.
3.2.2 Biological replicates analysis
Preliminary analyses performed with CIRI on the dataset allowed us to detect
11 148 different putative circRNAs expressed throughout the haematopoietic tree.
Forty-one percent of these circRNAs are exonic, 42 % are intronic and the remaining
map on unannotated regions of the genome (Figure 3.5).
Figure 3.6 and Table 3.2 give a detailed overview of the number of circRNAs
detected in each sample and in particular the overlap within each cell type. The
detected circRNAs are scarcely shared by the biological replicates of each cell type:
only 0.77 % on average is present in every replicate, and only 4.49 % on average is
present in at least two replicates.
3.2.3 Comparison of circRNA-ome expression in different
cell types
In each cell population on average 15 % of the total circRNAs detected considering
all the cell types in the tree is present. The large majority of circRNAs (87.5 %) was
detected only in one of the eight cell types, thus every cell population has a specific
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Figure 3.6: Overview of the overlap of the circRNAs retrieved in the three different biological
replicates for each cell type. Samples are identified by the acronym of the corresponding
cell type and the last digits of the sample ID, as they appear in Table 3.2; for example
HSC_68102 identifies sample EGAN00001068102 of cell type HSC.
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Cell type Sample ID circRNAs Total Common to 3 Common to 2
HSC
EGAN00001068102 179
EGAN00001076149 246 1301 3 0.23 % 37 2.84 %
EGAN00001076170 916
MPP
EGAN00001068106 674
EGAN00001076171 1054 2320 26 1.12 % 121 5.22 %
EGAN00001095875 517
CLP
EGAN00001076172 803
EGAN00001095777 99 1225 1 0.08 % 26 2.12 %
EGAN00001096977 200
CMP
EGAN00001068103 727
EGAN00001068108 458 1654 21 1.27 % 113 6.83 %
EGAN00001076151 603
GMP
EGAN00001068104 1167
EGAN00001076152 794 2951 23 0.78 % 136 4.61 %
EGAN00001076173 1149
MEP
EGAN00001068105 615
EGAN00001068109 574 1987 22 1.11 % 114 5.74 %
EGAN00001076150 934
MK
EGAN00001095825 273
EGAN00001095842 227 1491 17 1.14 % 59 3.96 %
EGAN00001091941 202
EB
EGAN00001095770 173
EGAN00001095771 114 937 4 0.43 % 43 4.59 %
EGAN00001095772 165
Means 1733 0.77 % 4.49 %
Table 3.2: Summary of circRNAs found in each considered cell type and sample. Total:
circRNAs found in at least one biological replicate of each cell type. Common to 3: the
circRNAs present in all biological replicates of a specific cell type and the percentage
with respect to the total. Common to 2: the circRNAs present in at least 2 biological
replicates of a specific cell type and the percentage with respect to the total.
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Figure 3.7: Heatmap of the expression levels (sum of the expression levels of the biological
replicates of each cell type) of the 11 148 circRNAs in the dataset. For every cell type there
is a well defined set of circRNAs, mostly not detect in the other cell types. Clustering is
performed on the rows with Euclidean distance method. Darker colours indicate higher
number of reads spanning the backsplicing junction.
set of expressed circRNAs.
Around 65% of circRNAs detected in each cell type are ‘unique’, meaning that
they are detected specifically in one cellular population only; thus the remaining
30–40 % is present in at least two cell types (Figure 3.7 and Table 3.3).
Considering previously reported poor overlap amongst circRNAs sets expressed
by biological replicates, we reasoned that a more robust set of circRNAs in the
dataset is represented by the circRNAs detected in all the biological replicates of all
cell types: of the 11 148 detected circRNAs, 20 match this requirement.
Most of these circRNAs display very similar expression levels across different cell
types (Figure 3.8). We can speculate that this subset of circRNAs could be part of a
housekeeping set of circRNAs in the haematopoietic compartment. Therefore it
would be interesting to check the expression of these circRNAs in cell types outside
the haematopoietic compartment.
Amongst the 20 circRNAs in this short list, 14 derive from ten known genes.
The other 6 derive from genomic regions annotated as intergenic. MALAT1 and
MAN1A2 are associated to 3 circular isoforms in this subset: this is in line with
the observed percentage of 31 % of genes expressing at least 2 circular isoforms
(Figure 3.2). Table 3.4 summarises the genes of origin of the circRNAs displayed in
Figure 3.8; all genes have ubiquitous expression amongst different tissues.
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Cell type Total Unique Shared
HSC 1301 970 74.56 % 331 25.44 %
MPP 2320 1655 71.34 % 665 28.66 %
CLP 1225 845 68.98 % 380 31.02 %
CMP 1654 1075 64.99 % 579 35.01 %
GMP 2951 2287 77.50 % 664 22.50 %
MEP 1987 1326 66.73 % 661 33.27 %
MK 1491 1038 69.62 % 453 30.38 %
EB 937 548 58.48 % 389 41.52 %
Table 3.3: Summary of the comparison between the different cell types. Total: all circRNAs
found in each cell type (non redundant). Unique: circRNAs only found in the specific
cell type and percentage with respect to the total. Shared: circRNAs of each cell type
that are also found in other cell types and percentage with respect to the total.
Figure 3.8: Heatmap of the expression levels (sum of the expression levels of the biological
replicates of each cell type) of the 20 circRNAs shared by all cell types. Clustering is
performed on the rows with Euclidean distance method. Darker colours indicate higher
number of reads spanning the backsplicing junction.
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3.3 Discussion and conclusions
The pilot studywas designed to start handling RNA-seq data for circRNA retrieval,
being this the first time for our group to investigate these molecules. Despite the
polyA enrichment procedure to which the sequenced RNA had been subjected we
were able to detect a large number of circRNAs. Their expression levels can not
be definitely established because of the random selection of circRNAs that were
actually sequenced.
The analysis of technical replicates highlighted that there is a high consistency
in the detected circRNAs found by CIRI. The analysis of the biological replicates
instead showed that there is high variability in the detected circRNAs in the samples
of the same cell type. In this pilot analysis we exploited available data implement-
ing innovative analyses with increased discovery power: we were able to retrieve
circRNAs in specific cell types of interest, even if with quite simple analyses ground-
ing on a suboptimal dataset. In the next chapter we will present more detailed and
meaningful results regarding circRNA expression studied with an advanced version
of the circPipeline thanks to a custom designed dataset, showing that studying
circRNAs adds important elements to transcriptome definition at a better resolution.
Obviously available RNA-seq datasets represent a rich mine for future studies to
identify and characterize the circRNA-ome.
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4.1 Methods
4.1.1 Samples collection and cell sorting
The samples were collected thanks to the collaboration with the Centro Trasfu-
sionale of Padua Hospital, that granted us the access to peripheral blood of adult
healthy donors.
Each whole blood sample was processed within 24 hours after the collection.
Treatment with Lymphoprep™ by STEMCELL™ Technologies followed by haemol-
ysis allowed the separation of the mononuclear cells with low red blood cells carry
over. The cells were sorted with FACS Aria™ III of Becton Dickson after anti-
body marking (all used antibodies are produced by Beckman Coulter). Gating on
CD45+ was used to isolate leukocyte cell populations and additional more specific
markers (CD19+, CD3+ and CD14+) allowed to sort B cells, T cells and Monocytes
respectively.
4.1.2 RNA extraction
The sorted cells were lysed with TRIzol™ by Invitrogen™ according to man-
ufactural indications, and the RNA was extracted with chloroform, precipitated
with isopropanol and washed with ethanol. The quality of the extracted RNA was
assessed with Agilent 2100 Bioanalyzer and the final concentration with Qubit™
fluorometer. Only samples with RNA integrity measure (RIN) greater than 7 and
with a concentration of at least 50 ng/µg were considered suitable for sequencing
(Table 4.1).
4.1.3 Library preparation and sequencing (RNA-seq)
RNA-seq was performed by IGA Biotechnology sequencing service. The library
was prepared with TruSeq Stranded Total RNA Ribo-Zero Gold kit, to enrich the
total RNA in non-ribosomal sequences. Mate-paired reads 100–125 bp long were
produced with Illumina® HiSeq2000 instrument, with sequencing depth of 120
million reads per sample (Panel 4.1).
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Sample ID Cell type Sex Sorted cells RIN RNA concentration
(ng/µg)
b05 CD19+ M 3 900 000 7.30 43.4
b07 CD19+ M 4 500 000 7.80 110.0
b13 CD19+ M 3 900 000 7.80 69.9
b14 CD19+ F 2 300 000 8.50 188.0
m05 CD14+ M 3 400 000 9.10 95.6
m06 CD14+ F 4 800 000 7.80 76.2
m07 CD14+ M 4 500 000 8.00 99.4
m08 CD14+ M 4 800 000 9.00 1180.0
t01 CD3+ F 7 800 000 8.60 63.6
t07 CD3+ M 5 000 000 8.30 151.0
t12 CD3+ M 7 500 000 8.40 232.0
t14 CD3+ F 2 500 000 8.40 306.0
Table 4.1: Description of collected samples, indicating cell type, sex of the donor, number
of cells obtained after sorting, RNA integrity number (RIN) and final concentration of
RNA.
Sample ID Reads
b05 118 585 032
b07 129 235 360
b13 108 236 716
b14 142 565 832
m05 192 086 930
m06 146 374 148
m07 124 539 144
m08 131 493 682
t01 166 967 662
t07 172 067 828
t12 182 155 352
t14 151 858 242
0.0e+00
5.0e+07
1.0e+08
1.5e+08
2.0e+08
b05 b07 b13 b14 m05 m06 m07 m08 t01 t07 t12 t14
Sample.id
S
eq
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Celltype
B cells
Monocytes
T cells
Panel 4.1: Sequencing summary. Sequencing depth for each considered sample: sequenced
reads are enumerated in the table and sequenced bases per sample are illustrated in the
bar plot.
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Figure 4.1: Proportions of reads collinearly mapped (blue) and unmapped (red) to the
reference genome for each sample; unmapped reads contain the reads harbouring the
backsplicing junction, which is used to detect circRNAs.
4.2 Results
4.2.1 CircRNAs detection and description
The preliminary HISAT2 reads alignment to reference genome (see Chapter 2
for additional details) is the first analysis step used to separate reads mapping
collinearly to be fed to the linear branch of the pipeline and those unmapped to
be fed to the circular branch of the pipeline. On average 91 % of the reads were
mapped for each sequenced sample, the ratio between mapped and unmapped reads
in different samples is displayed in Figure 4.1. B cells have a smaller fraction of
reads unmapped to the linear portion, 4.2 million reads on average, compared to
11.5 millions for T cells and 10.7 millions for Monocytes, which could indicate a
smaller circRNA-ome in this cell type.
CircRNAs detection grounded on the use of four different programs in parallel;
each of them detected different amounts of backsplices, ranging from 1029 for
CIRCexplorer to more than 330 000 for Testrealign (Table 4.2). The integration of
the sets of circRNAs detected by the four programs produced a set of 350 299 putative
circRNAs detected by at least one method. Of the total, 116 644 circRNAs were
selected after filtering according to backsplice end distance (at least 200 nucleotides)
and the number of reads spanning the backsplicing junction (at least 2 reads). The
results are summarized in Table 4.2. Despite the algorithm differences between
CIRI, Find_circ and Testrealign (that also find different numbers of circRNAs in
the same data), their distributions of backsplice ends distances and reads numbers
are similar (Figure 4.2). Both for backsplice ends distances and reads numbers
CIRCexplorer marks an exception, which is probably due to the significantly lower
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Program Total > 200 nt > 2 reads Selected
CIRCexplorer 1029 97.8 % 51.4 % 47.7 %
CIRI 30 710 99.7 % 100.0 % 99.5 %
Find_circ 26 223 98.8 % 100.0 % 97.9 %
Testrealign 330 821 81.9 % 40.5 % 29.2 %
Table 4.2: Summary of the number of unique circRNAs detected by each program in
the whole set of considered cell types and samples. The second column reports the
percentages of circRNAs longer than 200 nucleotides identified by each program; the
third column displays the percentages of circRNAs covered by at least 2 backsplicing
reads; the fourth contains the percentages of circRNAs passing both the applied filters
and considered for further analyses; the percentages are calculated with respect to the
initial total number of circRNAs.
number of circRNAs it detected. Figure 4.2 also shows that B cells tend to have
lower backsplice ends distances than Monocytes and T cells, according to all used
programs.
Selection of a more robust subset of circRNAs Panel 4.2 shows the overlap
of circRNAs sets detected by the four programs. Find_circ and CIRI show high
concordance: 83 % of circRNAs found by CIRI are also detected by Find_circ. Only
82 circRNAs (0.07 % of the total) have been detected by all the programs, while
10 321 (8.8 % of the total) are detected by at least three programs and 26 211 (22 %)
are detected by at least two programs. On average 79 % of the circRNAs detected
by one program is also found by at least one of the other programs.
The distribution of the distances of the backsplices is more symmetric for
circRNAs detected by at least two programs, while those ‘exotic’ to one program dis-
play a more skewed distribution towards shorter backsplicing junctions. CIRI is the
program that identifies the longest circRNAs not detected by other programs, thus
displaying a distribution skewed on the other direction. In general the circRNAs
detected by at least two programs are those with the highest numbers of reads span-
ning the backsplicing junction, with respect to the exotic ones. CIRCexplorer has
the opposite trend, but this observation can not be considered significant because
of the 10× lower amount of detected circRNAs compared to the other programs
(Figure 4.3).
Summing up the observation that the 26 211 circRNAs detected by at least two
programs were more expressed than exotic ones, and considering previous data
from the study of Hansen et al. [85] we reasoned that this set of circRNAs probably
represents a more robust set to carry on for further analysis.
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Figure 4.2: Distributions of the distances of the backsplice ends (top) and of the numbers
of backsplice junction reads (bottom) for the circRNAs detected by each program in
each sample.
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Category CircRNAs
Shared by 2 15 808
Shared by 3 10 321
Shared by 4 82
Only CIRCexplorer 307
Only CIRI 5582
Only Find_circ 3133
Only Testrealign 81 411
Panel 4.2: Overlap of circRNA discovery results obtained with the four programs. The Venn
diagram displays the overlap of circRNAs detected by different numbers of methods
or only by one method. The table and the bottom left plot summarise the number
of circRNAs present in the various categories deriving from the overlap. The bottom
right plot displays for each program the proportion of circRNAs that are unique to that
program or shared with at least another program.
56
4.2 Results
Figure 4.3: Distributions of the distances of the backsplice ends (top) and of the numbers
of backsplice junction reads (bottom) for circRNAs detected by different numbers of
methods or only by one method in each sample for each program.
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Figure 4.4: Distribution of the frequencies of circular isoforms per gene: on the x axis the
number of isoforms produced by a certain gene, on the y axis the frequency of genes
producing a certain number of circular isoforms. For example, the first bar indicates
that there are 2821 genes producing 1 circular isoform. The last point on the x axis, 640,
represents the circRNAs which have not been annotated to a specific gene, hence for
which we can not establish if there are different circular isoforms.
CircRNA isoforms deriving from the samegene in the selected subset The
subset of 26 211 circRNAs is expressed by 7307 different genes. Of these genes,
2821 (39 % of the total) produced only one circular isoform, while the remaining
61 % produced at least 2 circRNA isoforms: Figure 4.4 shows the distribution of
the number of genes ranked according to the number of different circRNAs per
gene. In particular 1364 genes (19 %) produce 2 circular isoforms and 1619 genes
(22 %) express 3–5 different circRNAs each. Some examples of multiple circular
isoforms expressed from a single gene are displayed in Figure 4.5. In these examples
backsplicing positions prevalently overlap the boundaries of exons, and backsplicing
ends fall in different exons. Circ_AFF1_iso1 and circ_MAN1A2_iso7 can contain at
most the two exons on which the backsplicing ends map and the intron in between,
while the other circular isoforms are potentially multi-exonic and multi-intronic
because the backsplice ends map on non-contiguous exons, thus displaying a more
complex pattern of exon combinations.
CircRNA type classification of the selected subset Of the selected 26 211
circRNAs the majority (22 562, 86 %) is ‘exonic’ (like those displayed in Figure 4.5),
meaning that both the donor and acceptor site of its backsplice junction maps on
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Figure 4.5: Examples of genes expressing more than one circular isoform. Black boxes
represent the genomic region comprised between the detected backsplice ends of the
three circRNAs deriving from the gene AFF1 on chromosome 4 (top) and of the seven
circRNAs deriving from the gene MAN1A2 on chromosome 1 (bottom).
exonic sequences. ‘Intronic’ circRNAs — in which at least one of the ends of the
backsplice maps on an intron — are 3010 (12 %), while ‘intergenic’ ones, mapping
on unannotated regions of the genome, are 639 (2 %).
Considering exonic circRNAs, in 480 cases both backsplice ends map on the
same exon, thus these circRNAs are probably produced by the circularisation of a
single exon. CircRNAs of the latter subset for which the complete sequence can be
retrieved are suitable candidates for in silico functional predictions. For circRNAs
with backsplice ends far in the genome, spanning a region including two or more
exons and the corresponding introns, the determination of the exact circRNA
structure (included exons and retained introns) requires additional experimental
analyses informing on circRNAs length or sequence.
Indication of robustness of our results The robustness of the selected set
of detected circRNA has been tested by comparing our results with those of the
previously mentioned article by Hansen et al. [85], referring to circRNAs detected
in human fibroblast resulting ‘enriched’, ‘unchanged’ or ‘depleted’ by RNAse R
treatment. Only about a hundred of circRNAs detected in blood cells were also
detected in their samples, which was expected considering the very different cell
types compared. Notably, 90 % of the overlapping circRNAs are categorized as
‘enriched’ in their study. This means that the exact same backsplicing junction
was detected in human fibroblasts and blood cells and was not depleted by the
treatment with RNAse R. This result gives a positive although indirect indication
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Cell type Total 4 samples ≥ 3 samples ≥ 2 samples Private
B cells 16 678 2526 4697 7995 8683
Monocytes 9649 1289 2376 4311 5338
T cells 18 226 1944 4124 8104 10 122
Panel 4.3: For each of the three considered cell types, the Venn diagrams and the table
display and summarise the overlap of circRNAs detected in each biological replicate of
the cell type.
that the majority of backsplicing junctions we detected are actually associated to
circular molecules providing confidence about our results.
4.2.2 Comparison of circRNAs expressed in B cells, T cells
and Monocytes
Panel 4.3 shows the overlap of the circRNAs detected in the three cell types: in
B cells the pipeline detected 16 678 circRNAs, that is 64 % of the total circRNAs, in
Monocytes 9649 (37 %) and in T cells 18 226 (70 %). In B cells 15 % of the detected
circRNAs are detected in all of the four samples, 13 % of the circRNAs in Monocytes
are shared by all four samples, and 10 % are shared by all T cells samples.
Of the total 26 211 detected circRNAs, 5293 (20 %) are expressed in each of the
three considered cell types, 29.6 % are expressed in two cell types and 50.2 % are
‘private’ to one cell type at a time. It should be noted that the number of private
circRNAs is highly variable across the twelve samples.
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Figure 4.6: Venn diagram displaying the overlap of circRNAs expressed in the three cell
types.
Regarding circRNAs specific of each cell type, 5067 (19 % of the total 26 211
circRNAs) are only detected in B cells, 6041 (23 %) are only detected in T cells and
2054 (8 %) are only detected in Monocytes (Figure 4.6). Monocytes, the cell type
with less circRNAs detected — despite the highest number of sequenced bases and
the highest ratio of mapped/unmapped reads — have nearly all of their circRNAs,
92 %, detected in at least another cell type. The number of circRNAs that are in
common to the two lymphocytic population, 5454 (which is 32 % of their circRNAs
on average), is much higher than the number of circRNAs that they share with
Monocytes, that accounts for the 6 % of their total number of circRNAs.
4.2.3 CircRNAs expression profiles variability in considered
cell types: descriptive analyses results
Descriptive analyses were performed to summarise the expression levels of the
set of selected circRNAs, and to try and identify expression patterns throughout
the different samples. For every circRNA, each of the backsplice detection methods
provides an expression estimation. For circRNAs detected by two or more methods
the expression level in each sample was calculated as the median value of the
expression levels calculated by each program, after normalization of the values (see
Section 2.4.2).
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Figure 4.7: Distance plot of the different samples according to expression profiles of 26 211
circRNA detected by at least two methods (the more intense the blue colour, the more
similar the samples pairwise, according to Euclidean distance).
Unsupervised clustering analysis was performed on the selected set of 26 211
circRNAs and revealed the tendency of the samples belonging to the same cell
type to cluster together, except the separation is not perfect. Figure 4.7 displays
the distance plot obtained by correlating the expression levels of the samples, that
shows the above mentioned tendency of the various samples of each cell type to
cluster together. Similar results are obtained by principal component analysis (PCA):
Figure 4.8 shows the PCA plot obtained by considering the first two components
describing the expression levels of the circRNAs. These two principal components,
that account for less that 60 % of the total variance across sample, are incapable to
segregate the cell types, meaning that the variance to be explained is to high.
This issue is probably due to the high level of background noise determined
by circRNAs only present in one sample. The latter results in a high number of
circRNAs with the same expression profile pattern: a certain number of sequencing
reads is present in one sample only, but each of the remaining 11 samples has 0
sequencing reads.
Biological replicates analysis Taking the analysis to a deeper level we next
examined the circRNAs expressed by the four replicates in each cell type. When
considering only the circRNAs private to any given cell type (non-overlapping
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Figure 4.8: Principal component analysis of the different samples according to expression
profiles of 26 211 circRNAs detected by at least two methods.
circRNAs in Figure 4.6), the overlap of the four samples allows to identify the
circRNAs that are expressed in all samples of each cell type (Figure 4.9). Eighty-
nine circRNAs are typical of B cells (2 %), 55 typical of Monocytes (3 %), and 43
typical of T cells (1 %). In this comparison the majority of circRNAs are private to
one sample, 60 % for B cells, 78 % for Monocytes, and 80 % for T cells.
We reasoned that circRNAs with consistent expression in a given cell type will
represent a more robust set to be used for a biologically relevant comparison across
cell types. We thus selected the subset of 12 276 (47 % of the total) circRNAs detected
in at least 2 samples of each cell type.
The unsupervised clustering analysis on this subset considering the correlation
between the samples resulted in a more clear separation between the three cell types
(Figure 4.10). The three cell types in fact do cluster almost perfectly, indicating that
variations of circRNAs expression profiles reflect differences between cell types
and that there actually are circRNAs expression specificities of each cell type, in
terms of circRNAs. Moreover the PCA plot is highly significant with the two used
principal components accounting for 59 % of the observed variance between the
cell types. The two principal components used for this analysis are strong enough
to clearly separate the samples according to the cell type.
The unsupervised clustering performed with Pearson’s method on all 12 276
circRNAs perfectly separates the three cell types, but still the heatmap displays
a high degree of background noise (Figure 4.11). This background noise is due
to the presence of a high number of circRNAs with very low expression values
throughout the samples (light blue in Figure 4.11) that do not allow to efficiently
cluster the expression levels. The same analysis on the 1000 circRNAs with the
highest variation coefficient (mean normalized variance) across all considered
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Figure 4.9: Venn diagrams displaying the overlap of circRNAs detected only in one of the
three cell types when comparing the four samples of each cell type.
samples highlights the presence of subsets of circRNAs that are more specifically
expressed in one cell type whereas some circRNAs are expressed in two cell types
at distinct levels (Figure 4.12).
4.2.4 CircRNAs differential expression analysis
The above illustrated descriptive analysis gives a strong indication of the pres-
ence of differentially expressed circRNAs in the three cell types. One of the main
aims of the study was the identification of expression specificities of considered
differentiated blood cell types. Therefore differential expression analysis was per-
formed on the whole set of 26 211 circRNAs detected by at least two methods. For
each pairwise comparison (B cells vs. Monocytes, B cells vs. T cells and Monocytes
vs. T cells) DESeq2 analysis with false discovery rate threshold of 0.05 identified
a subset of circRNAs with significant differential expression: 2589, 168 and 977
respectively (see Table 4.3).
We also identified a subset of circRNAs differentially expressed in a certain cell
type compared to both the other two. In particular 74 circRNAs are more expressed
in B cells compared to Monocytes and T cells, 40 are more expressed in T cells, and
159 are more expressed in Monocytes, for a total of 273 circRNAs upregulated in
one cell type compared to the other two.
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Figure 4.10: Unsupervised analyses describing the similarity of different samples according
to expression profiles of 12 276 circRNAs detected by at least two methods and in at
least 2 samples of each cell type: distance plot (top; the more intense the blue colour,
the more similar the samples pairwise, according to Euclidean distance) and PCA plot
(bottom) of the different samples according to selected circRNAs expression profiles.
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Figure 4.11: Heatmap of expression profiles of 12 276 circRNAs detected by at least two
methods and in at least 2 samples of each cell type, showing also unsupervised clustering
of samples and cell types.
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Figure 4.12: Heatmap of expression profiles of the 1000 circRNAs with the highest variation
coefficient across considered samples among circRNA detected by at least two methods
and in at least 2 samples of each cell type, showing also unsupervised clustering of
samples and cell types.
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Comparison Total padj < 0.05 log2 FC < 0 log2 FC > 0
B vs. M 19 666 2589 13.0 % 2037 10.0 % 552 3.0 %
B vs. T 24 039 168 0.7 % 99 0.4 % 69 0.3 %
M vs. T 20 693 977 5.0 % 245 1.0 % 732 4.0 %
Table 4.3: Summary of the differential expression analysis. The first column displays the
actual number of performed comparisons between sample groups, while the second
column displays the number of significantly differentially expressed circRNAs (P-value
adjusted for multiple testing lower than 0.05 detected). The last two columns display sep-
arately the number of down- and up-regulated circRNAs respectively in the comparison,
and percentage over all the significantly differentially expressed circRNAs.
Functional enrichment based on genes producing circRNAs We decided
to perform functional enrichment analysis to identify pathways or tissues whose
genes are significantly enriched in a given sample, on the genes of the set of
differentially expressed circRNAs. This analysis was performed with DAVID testing
GO terms, UP_TISSUE and KEGG pathways databases. Many of the genes that
produce circRNAs that are differentially expressed in at least one of the analysed
cell types encode proteins that are involved in pathways and tissues related to
haematopoiesis. Significantly enriched KEGG pathways are VEGF, MAPK, RAS
signalling pathways, Lysine degradation pathway and Pathways in cancer; also
genes expressed in T cells, Bone Marrow, Platelets, Lymphoblasts and Lymph nodes
are enriched. Together with these very specific sets of genes also terms regarding
more general purpose pathways are enriched, such as GO terms Protein binding,
Membrane, ATP-binding, Cytosol and Cytoplasm. This analysis only gives an
indirect indication of the possible processes in which the differentially expressed
circRNAs are involved, and gives us an instrument to select a subset of circRNAs
that should be deeper analysed.
Short list of circRNAs based on differential expression and genes of origin
Amongst the circRNAs differentially upregulated in one cell type compared to the
others, and considering the presence of their origin gene in enriched pathways we
selected a short list of circRNAs with the highest log2 fold change (Table 4.4) to be
further investigated.
Some of these circRNAs are produced by genes that were identified in the func-
tional enrichment we performed. We checked for the presence of these circRNAs
in circBase [40]. Interestingly 11 of the circRNAs were retrieved in the database,
meaning they have already been detected in some of the datasets that are part of
circBase. This is yet another indirect indication on the reliability of our results. The
expression levels across the three cell types are displayed for some of the circRNAs
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in the short list in Figure 4.13. Many of the analysed circRNAs are solely expressed
in one of the cell types, thus the high fold change for which they were selected is
expected, while some are also present in other cell types with a specific level of
expression.
4.2.5 Relations among circRNAs and linear RNAs expressed
from the same genes
We next turned to the data produced by the linear branch of the pipeline, to
analyse the relationship between the expressed circRNAs and the linear transcripts
produced by the same genes in our dataset. It is reported [13] that the ratio between
the expression of circular and linear transcripts of the same gene is widely variable,
as there are circRNAs more expressed than the linear transcripts and vice versa.
The pipeline detected 39 345 genes expressed in Monocytes, 49 651 genes ex-
pressed in T cells and 53 010 genes expressed in B cells. Of these genes, in B cells
3.4 % of the genes contribute to the 95 % of the expression, for Monocytes this is
3.6 % and for T cells it is 4.3 % of the genes, meaning that the great majority of genes
have low expression levels. Figure 4.14 shows the distributions of expression levels
of genes per cell type and per sample.
Figure 4.15 displays the distribution of the values of correlation between the
expression levels of a circRNA and the expression level of the gene from which the
circRNA is produced. The distribution has a normal-like shape centred very near to
0 on R = 0.1, meaning that the expression levels of circRNAs and genes only have
a slight tendency to correlate. Correlations with R > 0 indicate that the linear and
the circular transcript have a similar expression level, whereas R < 0 indicates that
the expression levels of the circular and linear transcript are discordant, both with
the linear more expressed than the circular and the opposite and more intriguing
scenario of the circular more expressed than the linear transcript. Notably, most of
the pairs display a weak correlation, as 6665 pairs have absolute level of R lower
than 0.3 (69 % of the total pairs) or even display a strong but negative correlation:
975 (10 %) with R < −0.3.
4.3 Discussion
The analysis of our dataset is an important step further in the characterization and
understanding of blood cell circRNA-ome, which up to now was only preliminarily
studied. The only available study on circRNAs in blood cell with replicates to
increase true discovery rate is the one by Memczak et al., 2015 [5], which analysed
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Figure 4.13: Expression levels across all cell types of 12 differentially expressed circRNAs
in the short list summarised in Table 4.4.
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Figure 4.14: Distributions of expression levels of genes per cell type (left) and per sample
(right).
Figure 4.15: Distribution of the correlations between the expression levels of a gene and
the circRNAs deriving from the same gene.
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5 whole blood replicates. In this study they detected more than 28 000 circRNAs in
total using a single tool for retrieval, which is comparable with our robust set of
26 211 circRNAs identified with the use of four tools in parallel.
The four programs have radically different circRNAs detection yields, which is
due to the substantial differences of the algorithms they use. The different yields and
the low percentage of overlapping circRNAs across the programs has already been
pointed out by Hansen et al. in their 2015 study [85], suggesting the use of more
than one program in parallel as a strategy to overcome this issue. Experimental
technical validations are needed though to definitely assess the sensitivity and
specificity of this approach to in silico detection.
Chen et al. in their 2014 study [3] analysed a high number of samples of 8
different cell types, but our re-analysis of their data only retrieved about one third
of the amount of circRNAs in our dataset. Given the high number of samples and
of different cell types a greater number of circRNAs would have been expected,
except this dataset had been obtained with polyA enrichment instead of ribosomal
RNA depletion. Ribosomal RNA depletion requires a higher amount of input RNA,
compared to polyA enrichment, but we can confirm that it ensures better results
on circRNAs detection, without the drawback of not allowing the calculation of a
precise expression level. It should also be noted that Chen et al. could have slightly
underestimated the expression levels of non-coding RNAs, because not all ncRNAs
are polyadenylated. A thorough analysis of the samples we sequenced, to estimate
the coding/non-coding transcripts ratio in different cell types, should be performed,
to be compared with the results of the above mentioned study, that indicated an
enrichment in coding transcripts in differentiated cell populations and of non-
coding transcripts in progenitors. Anyway revisiting publicly available datasets
treated with polyA enrichment can be useful for preliminary indications regarding
the presence of circRNAs in malignancies too. On this subject a very interesting role
is played by f-circRNAs, that are produced by fusion genes in genomic aberrations.
Publicly available RNA-seq datasets of haematological malignancies harbouring
genomic aberrations are thus perfect candidates for re-analysis focused on circRNAs
detection.
Considering the differences observed in the analysed cell types the whole of
these analyses will result in the definition of subsets of circRNAs putatively relevant
in the biology of the analysed cells. These subsets of circRNAs can be compared
with circRNAs described in literature or present in databases, to see if some of
them have already been detected or at least if other circular isoforms from the same
gene have been described. Preliminary analyses in this sense have been performed
for circRNAs short-listed for their differential expression or for the function of
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the gene producing them according to the functional enrichments performed,
that highlighted that many of the genes involved in circRNAs production belong
to haematopoiesis or cancer related pathways, such as PAX5, SETBP1, CDK14,
BCL11Band AFF2. Interestingly enough, detected circRNAs of these genes have
already been retrieved in other studies performed on cell lines, CD19+ cells and
brain region samples. This piece of information strongly indicates the convenience
of prioritising these circRNAs both for technical and biological validation, in order
to start functional studies to characterise their role in the cell types in which are
up significantly expressed.
Complete functional predictions though can also be performed for circRNAs
whose sequence is known, as in the case of circularised single-exon, for example
for TRABD2A, AFF2, TET2 and VCAN of our short list. Furthermore preliminary
functional predictions can be performed on the sequence covered by backsplicing
reads, that is a sequence not existing in the reference genome, which could harbour
newly formed binding sites or sequence motifs. Given the interesting features of
the short-listed set of circRNAs they will be prioritised for experimental validation.
As previouslymentioned experimental validation is needed to complete this study
and to give a start to functional experiments. First of all putative circRNAs should
be technically validated, namely their actual expression in the samples in which
they were retrieved should be experimentally tested, to obtain indications on the
specificity of the four used programs and on the false discovery rate of the pipeline.
To perform this technical validation circRNAs with diverse expression levels should
be tested in the original samples. Furthermore to speculate on the sensitivity of the
circRNAs detection of the circPipeline, some circRNAs with low expression levels
should be considered for experimental validation. Next the validated circRNAs
should be tested for detection in other samples of the same cell type to check if the
expression pattern described in the samples we sequenced is reproducible, i.e. if a
circRNAs is present in all samples of our dataset, it should be also present in any
other sample of the same tested cell type.
4.3.1 Conclusions
This project allowed to acquire novel and deeper knowledge on circRNAs in
healthy haematopoietic compartment, and besides on the methods useful to their
detection, characterisation and analysis from RNA-seq data. The development of
the semi-automated pipeline allows to perform these analyses in a reproducible way
with increased true positive detection rate, compared to the methods previously
available.
The identification of a high number of circRNAs, many of which with differential
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expression in blood cell types, together with the great interest of some circRNAs
because of the gene from which they derive, encourages to take the analyses a step
further. Once the functional characteristics of these circRNAs have been described
in normal haematopoiesis, the behaviour of these molecules in haematopoietic
malignancies should be thoroughly analysed.
This more refined and complete analysis of the transcriptome in normal haema-
topoiesis will allow to unveil mechanisms underlying cellular processes in healthy
condition and to better understand their dysregulation in haematologic malignan-
cies.
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